Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Oct;8(4):515–548. doi: 10.1128/cmr.8.4.515

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

T G Mitchell 1, J R Perfect 1
PMCID: PMC172874  PMID: 8665468

Abstract

Although Cryptococcus neoformans and cryptococcosis have existed for several millennia, a century has passed since the discovery of this encapsulated yeast and its devastating disease. With the advent of the AIDS pandemic, cryptococcal meningitis has emerged as a leading cause of infectious morbidity and mortality and a frequently life-threatening opportunistic mycosis among patients with AIDS. Both basic and clinical research have accelerated in the 1990s, and this review attempts to highlight some of these advances. The discussion covers recent findings, current concepts, controversies, and unresolved issues related to the ecology and genetics of C. neoformans; the surface structure of the yeast; and the mechanisms of host defense. Regarding cell-mediated immunity, CD4+ T cells are crucial for successful resistance, but CD8+ T cells may also participate significantly in the cytokine-mediated activation of anticryptococcal effector cells. In addition to cell-mediated immunity, monoclonal antibodies to the major capsular polysaccharide, the glucuronoxylomannan, offer some protection in murine models of cryptococcosis. Clinical concepts are presented that relate to the distinctive features of cryptococcosis in patients with AIDS and the diagnosis, treatment, and prevention of cryptococcosis in AIDS patients.

Full Text

The Full Text of this article is available as a PDF (744.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allendoerfer R., Marquis A. J., Rinaldi M. G., Graybill J. R. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. Antimicrob Agents Chemother. 1991 Apr;35(4):726–729. doi: 10.1128/aac.35.4.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson D. M., Dykstra M. A. Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans. Mycopathologia. 1984 Jun 30;86(3):169–177. doi: 10.1007/BF00441128. [DOI] [PubMed] [Google Scholar]
  3. Ankenbauer R. G., Nester E. W. Sugar-mediated induction of Agrobacterium tumefaciens virulence genes: structural specificity and activities of monosaccharides. J Bacteriol. 1990 Nov;172(11):6442–6446. doi: 10.1128/jb.172.11.6442-6446.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Armonda R. A., Fleckenstein J. M., Brandvold B., Ondra S. L. Cryptococcal skull infection: a case report with review of the literature. Neurosurgery. 1993 Jun;32(6):1034–1036. doi: 10.1227/00006123-199306000-00028. [DOI] [PubMed] [Google Scholar]
  5. Arrington J. A., Murtagh F. R., Martinez C. R., Schnitzlein H. N. CT of multiple intracranial cryptococcoma. AJNR Am J Neuroradiol. 1984 Jul-Aug;5(4):472–473. [PMC free article] [PubMed] [Google Scholar]
  6. BAKER R. D., HAUGEN R. K. Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases. Am J Clin Pathol. 1955 Jan;25(1):14–24. doi: 10.1093/ajcp/25.1.14. [DOI] [PubMed] [Google Scholar]
  7. BARRON C. N. Cryptococcosis in animals. J Am Vet Med Assoc. 1955 Aug;127(941):125–132. [PubMed] [Google Scholar]
  8. BENHAM R. W. Cryptococcosis and blastomycosis. Ann N Y Acad Sci. 1950 Sep;50(10):1299–1314. doi: 10.1111/j.1749-6632.1950.tb39828.x. [DOI] [PubMed] [Google Scholar]
  9. BLOOMFIELD N., GORDON M. A., ELMENDORF D. F., Jr DETECTION OF CRYPTOCOCCUS NEOFORMANS ANTIGEN IN BODY FLUIDS BY LATEX PARTICLE AGGLUTINATION. Proc Soc Exp Biol Med. 1963 Oct;114:64–67. doi: 10.3181/00379727-114-28586. [DOI] [PubMed] [Google Scholar]
  10. Baker R. D. The primary pulmonary lymph node complex of crytptococcosis. Am J Clin Pathol. 1976 Jan;65(1):83–92. doi: 10.1093/ajcp/65.1.83. [DOI] [PubMed] [Google Scholar]
  11. Baldwin G. C., Fleischmann J., Chung Y., Koyanagi Y., Chen I. S., Golde D. W. Human immunodeficiency virus causes mononuclear phagocyte dysfunction. Proc Natl Acad Sci U S A. 1990 May;87(10):3933–3937. doi: 10.1073/pnas.87.10.3933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Batchelor B. I., Brindle R. J., Waiyaki P. G. Clinical isolates of HIV-associated cryptococcosis in Nairobi, Kenya. Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):85–85. doi: 10.1016/0035-9203(94)90512-6. [DOI] [PubMed] [Google Scholar]
  13. Baughman R. P., Rhodes J. C., Dohn M. N., Henderson H., Frame P. T. Detection of cryptococcal antigen in bronchoalveolar lavage fluid: a prospective study of diagnostic utility. Am Rev Respir Dis. 1992 May;145(5):1226–1229. doi: 10.1164/ajrccm/145.5.1226. [DOI] [PubMed] [Google Scholar]
  14. Begue R. E., Lindo-Soriano I. Failure of intrathecal tetanus antitoxin in the treatment of tetanus neonatorum. J Infect Dis. 1991 Sep;164(3):619–620. doi: 10.1093/infdis/164.3.619. [DOI] [PubMed] [Google Scholar]
  15. Belay T., Cherniak R., Shinoda T. Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay. Infect Immun. 1993 Jul;61(7):2879–2885. doi: 10.1128/iai.61.7.2879-2885.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bennett J. E., Bailey J. W. Control for rheumatoid factor in the latex test for cryptococcosis. Am J Clin Pathol. 1971 Sep;56(3):360–365. doi: 10.1093/ajcp/56.3.360. [DOI] [PubMed] [Google Scholar]
  17. Bennett J. E., Dismukes W. E., Duma R. J., Medoff G., Sande M. A., Gallis H., Leonard J., Fields B. T., Bradshaw M., Haywood H. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med. 1979 Jul 19;301(3):126–131. doi: 10.1056/NEJM197907193010303. [DOI] [PubMed] [Google Scholar]
  18. Berlin L., Pincus J. H. Cryptococcal meningitis. False-negative antigen test results and cultures in nonimmunosuppressed patients. Arch Neurol. 1989 Dec;46(12):1312–1316. doi: 10.1001/archneur.1989.00520480054020. [DOI] [PubMed] [Google Scholar]
  19. Berry A. J., Rinaldi M. G., Graybill J. R. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother. 1992 Mar;36(3):690–692. doi: 10.1128/aac.36.3.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Beyt B. E., Jr, Waltman S. R. Cryptococcal endophthalmitis after corneal transplantation. N Engl J Med. 1978 Apr 13;298(15):825–826. doi: 10.1056/NEJM197804132981506. [DOI] [PubMed] [Google Scholar]
  21. Bhattacharjee A. K., Bennett J. E., Glaudemans C. P. Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis. 1984 Sep-Oct;6(5):619–624. doi: 10.1093/clinids/6.5.619. [DOI] [PubMed] [Google Scholar]
  22. Bindschadler D. D., Bennett J. E. Serology of human cryptococcosis. Ann Intern Med. 1968 Jul;69(1):45–52. doi: 10.7326/0003-4819-69-1-45. [DOI] [PubMed] [Google Scholar]
  23. Birkmann L. W., Bennett D. R. Meningoencephalitis following enucleation for cryptococcal endophthalmitis. Ann Neurol. 1978 Nov;4(5):476–477. doi: 10.1002/ana.410040518. [DOI] [PubMed] [Google Scholar]
  24. Blackie J. D., Danta G., Sorrell T., Collignon P. Ophthalmological complications of cryptococcal meningitis. Clin Exp Neurol. 1985;21:263–270. [PubMed] [Google Scholar]
  25. Blackstock R., Hall N. K. Immunosuppression by avirulent, pseudohyphal forms of Cryptococcus neoformans. Mycopathologia. 1982 Nov 19;80(2):95–99. [PubMed] [Google Scholar]
  26. Blackstock R., Zembala M., Asherson G. L. Functional equivalence of cryptococcal and haptene-specific T suppressor factor (TsF). I. Picryl and oxazolone-specific TsF, which inhibit transfer of contact sensitivity, also inhibit phagocytosis by a subset of macrophages. Cell Immunol. 1991 Sep;136(2):435–447. doi: 10.1016/0008-8749(91)90365-i. [DOI] [PubMed] [Google Scholar]
  27. Blackstock R., Zembala M., Asherson G. L. Functional equivalence of cryptococcal and haptene-specific T suppressor factor (TsF). II. Monoclonal anti-cryptococcal TsF inhibits both phagocytosis by a subset of macrophages and transfer of contact sensitivity. Cell Immunol. 1991 Sep;136(2):448–461. doi: 10.1016/0008-8749(91)90366-j. [DOI] [PubMed] [Google Scholar]
  28. Blanc M., Leuenberger P., Favez G. Cryptococcose pulmonaire invasive isolée. Présentation d'un cas. Schweiz Med Wochenschr. 1982 Mar 20;112(12):421–424. [PubMed] [Google Scholar]
  29. Bliska J. B., Guan K. L., Dixon J. E., Falkow S. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1187–1191. doi: 10.1073/pnas.88.4.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Blocher K. S., Weeks J. A., Noble R. C. Cutaneous cryptococcal infection presenting as vulvar lesion. Genitourin Med. 1987 Oct;63(5):341–343. doi: 10.1136/sti.63.5.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Bobak D. A., Washburn R. G., Frank M. M. C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes. J Immunol. 1988 Jul 15;141(2):592–597. [PubMed] [Google Scholar]
  32. Bodenhoff J. Development of strains of Cryptococcus neoformans resistant to nystatin, amphotericin B, trichomycin and polymyxin B. Acta Pathol Microbiol Scand. 1968;73(4):572–582. doi: 10.1111/j.1699-0463.1968.tb03215.x. [DOI] [PubMed] [Google Scholar]
  33. Bolaños B., Mitchell T. G. Killing of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol. 1989;27(4):219–228. [PubMed] [Google Scholar]
  34. Bolaños B., Mitchell T. G. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. J Leukoc Biol. 1989 Dec;46(6):521–528. doi: 10.1002/jlb.46.6.521. [DOI] [PubMed] [Google Scholar]
  35. Bolaños B., Mitchell T. G. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol. 1989;27(4):203–217. [PubMed] [Google Scholar]
  36. Boom W. H., Piper D. J., Ruoff K. L., Ferraro M. J. New cause for false-positive results with the cryptococcal antigen test by latex agglutination. J Clin Microbiol. 1985 Nov;22(5):856–857. doi: 10.1128/jcm.22.5.856-857.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Borton L. K., Wintroub B. U. Disseminated cryptococcosis presenting as herpetiform lesions in a homosexual man with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1984 Feb;10(2 Pt 2):387–390. doi: 10.1016/s0190-9622(84)80013-4. [DOI] [PubMed] [Google Scholar]
  38. Bottone E. J., Salkin I. F., Hurd N. J., Wormser G. P. Serogroup distribution of Cryptococcus neoformans in patients with AIDS. J Infect Dis. 1987 Jul;156(1):242–242. doi: 10.1093/infdis/156.1.242. [DOI] [PubMed] [Google Scholar]
  39. Bottone E. J., Toma M., Johansson B. E., Wormser G. P. Poorly encapsulated Cryptococcus neoformans from patients with AIDS. I: Preliminary observations. AIDS Res. 1986 Summer;2(3):211–218. doi: 10.1089/aid.1.1986.2.211. [DOI] [PubMed] [Google Scholar]
  40. Bottone E. J., Wormser G. P. Poorly encapsulated Cryptococcus neoformans from patients with AIDS. II. Correlation of capsule size observed directly in cerebrospinal fluid with that after animal passage. AIDS Res. 1986 Summer;2(3):219–225. doi: 10.1089/aid.1.1986.2.219. [DOI] [PubMed] [Google Scholar]
  41. Bozzette S. A., Larsen R. A., Chiu J., Leal M. A., Jacobsen J., Rothman P., Robinson P., Gilbert G., McCutchan J. A., Tilles J. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 1991 Feb 28;324(9):580–584. doi: 10.1056/NEJM199102283240902. [DOI] [PubMed] [Google Scholar]
  42. Braman R. T. Cryptococcosis (torulosis) of prostate. Urology. 1981 Mar;17(3):284–285. doi: 10.1016/0090-4295(81)90056-x. [DOI] [PubMed] [Google Scholar]
  43. Brandt M. E., Bragg S. L., Pinner R. W. Multilocus enzyme typing of Cryptococcus neoformans. J Clin Microbiol. 1993 Oct;31(10):2819–2823. doi: 10.1128/jcm.31.10.2819-2823.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Breen J. F., Lee I. C., Vogel F. R., Friedman H. Cryptococcal capsular polysaccharide-induced modulation of murine immune responses. Infect Immun. 1982 Apr;36(1):47–51. doi: 10.1128/iai.36.1.47-51.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Bruatto M., Vidotto V., Maina A. M. Growth of Cryptococcus neoformans in a thiamine-free medium. Mycopathologia. 1992 Sep;119(3):129–132. doi: 10.1007/BF00448808. [DOI] [PubMed] [Google Scholar]
  46. Brueske C. H. Proteolytic activity of a clinical isolate of Cryptococcus neoformans. J Clin Microbiol. 1986 Mar;23(3):631–633. doi: 10.1128/jcm.23.3.631-633.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Brummer E., Nassar F., Stevens D. A. Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing. Antimicrob Agents Chemother. 1994 Sep;38(9):2158–2161. doi: 10.1128/aac.38.9.2158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Brummer E., Stevens D. A. Macrophage colony-stimulating factor induction of enhanced macrophage anticryptococcal activity: synergy with fluconazole for killing. J Infect Dis. 1994 Jul;170(1):173–179. doi: 10.1093/infdis/170.1.173. [DOI] [PubMed] [Google Scholar]
  49. Buchanan K. L., Murphy J. W. Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun. 1994 Jul;62(7):2930–2939. doi: 10.1128/iai.62.7.2930-2939.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Buchmeier N. A., Heffron F. Induction of Salmonella stress proteins upon infection of macrophages. Science. 1990 May 11;248(4956):730–732. doi: 10.1126/science.1970672. [DOI] [PubMed] [Google Scholar]
  51. Bulmer G. S., Sans M. D. Cryptococcus neoformans. 3. Inhibition of phagocytosis. J Bacteriol. 1968 Jan;95(1):5–8. doi: 10.1128/jb.95.1.5-8.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Bulmer G. S., Sans M. D. Cryptococcus neoformans. II. Phagocytosis by human leukocytes. J Bacteriol. 1967 Nov;94(5):1480–1483. doi: 10.1128/jb.94.5.1480-1483.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Bulmer G. S., Tacker J. R. Phagocytosis of Cryptococcus neoformans by alveolar macrophages. Infect Immun. 1975 Jan;11(1):73–79. doi: 10.1128/iai.11.1.73-79.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Bulmer G. S. Twenty-five years with Cryptococcus neoformans. Mycopathologia. 1990 Feb;109(2):111–122. doi: 10.1007/BF00436791. [DOI] [PubMed] [Google Scholar]
  55. CAWLEY E. P., GREKIN R. H., CURTIS A. C. Torulosis; a review of the cutaneous and adjoining mucous membrane manifestations. J Invest Dermatol. 1950 May;14(5):327–344. [PubMed] [Google Scholar]
  56. CORPE R. F., PARR L. H. Pulmonary torulosis complicating pulmonary tuberculosis treated by resection. J Thorac Surg. 1954 Apr;27(4):392–398. [PubMed] [Google Scholar]
  57. Cameron M. L., Bartlett J. A., Gallis H. A., Waskin H. A. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis. 1991 Jan-Feb;13(1):64–67. doi: 10.1093/clinids/13.1.64. [DOI] [PubMed] [Google Scholar]
  58. Cameron M. L., Granger D. L., Matthews T. J., Weinberg J. B. Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J Infect Dis. 1994 Jul;170(1):60–67. doi: 10.1093/infdis/170.1.60. [DOI] [PubMed] [Google Scholar]
  59. Cameron M. L., Schell W. A., Bruch S., Bartlett J. A., Waskin H. A., Perfect J. R. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1993 Nov;37(11):2449–2453. doi: 10.1128/aac.37.11.2449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Campbell C. K., Payne A. L., Teall A. J., Brownell A., Mackenzie D. W. Cryptococcal latex antigen test positive in patient with Trichosporon beigelii infection. Lancet. 1985 Jul 6;2(8445):43–44. doi: 10.1016/s0140-6736(85)90093-5. [DOI] [PubMed] [Google Scholar]
  61. Campbell G. D. Primary pulmonary cryptococcosis. Am Rev Respir Dis. 1966 Aug;94(2):236–243. doi: 10.1164/arrd.1966.94.2.236. [DOI] [PubMed] [Google Scholar]
  62. Carey C. F., Mueller L., Fotopoulos C. L., Dall L. Bronchiolitis obliterans-organizing pneumonia associated with Cryptococcus neoformans infection. Rev Infect Dis. 1991 Nov-Dec;13(6):1253–1254. doi: 10.1093/clinids/13.6.1253. [DOI] [PubMed] [Google Scholar]
  63. Casadevall A., Freundlich L. F., Marsh L., Scharff M. D. Extensive allelic variation in Cryptococcus neoformans. J Clin Microbiol. 1992 May;30(5):1080–1084. doi: 10.1128/jcm.30.5.1080-1084.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Casadevall A., Mukherjee J., Devi S. J., Schneerson R., Robbins J. B., Scharff M. D. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis. 1992 Jun;165(6):1086–1093. doi: 10.1093/infdis/165.6.1086. [DOI] [PubMed] [Google Scholar]
  65. Casadevall A., Mukherjee J., Yuan R., Perfect J. Management of injuries caused by Cryptococcus neoformans--contaminated needles. Clin Infect Dis. 1994 Nov;19(5):951–953. doi: 10.1093/clinids/19.5.951. [DOI] [PubMed] [Google Scholar]
  66. Casadevall A., Spitzer E. D., Webb D., Rinaldi M. G. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother. 1993 Jun;37(6):1383–1386. doi: 10.1128/aac.37.6.1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Cauley L. K., Murphy J. W. Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect Immun. 1979 Mar;23(3):644–651. doi: 10.1128/iai.23.3.644-651.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Chang Y. C., Kwon-Chung K. J. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol. 1994 Jul;14(7):4912–4919. doi: 10.1128/mcb.14.7.4912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Chanock S. J., Toltzis P., Wilson C. Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen. Lancet. 1993 Oct 30;342(8879):1119–1120. doi: 10.1016/0140-6736(93)92106-4. [DOI] [PubMed] [Google Scholar]
  70. Chaskes S., Tyndall R. L. Pigment production by Cryptococcus neoformans and other Cryptococcus species from aminophenols and diaminobenzenes. J Clin Microbiol. 1978 Feb;7(2):146–152. doi: 10.1128/jcm.7.2.146-152.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Chechani V., Kamholz S. L. Pulmonary manifestations of disseminated cryptococcosis in patients with AIDS. Chest. 1990 Nov;98(5):1060–1066. doi: 10.1378/chest.98.5.1060. [DOI] [PubMed] [Google Scholar]
  72. Chen G. H., Curtis J. L., Mody C. H., Christensen P. J., Armstrong L. R., Toews G. B. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J Immunol. 1994 Jan 15;152(2):724–734. [PubMed] [Google Scholar]
  73. Cherniak R., Morris L. C., Anderson B. C., Meyer S. A. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect Immun. 1991 Jan;59(1):59–64. doi: 10.1128/iai.59.1.59-64.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Cherniak R., Morris L. C., Meyer S. A., Mitchell T. B. Glucuronoxylomannan of Cryptococcus neoformans obtained from patients with AIDS. Carbohydr Res. 1993 Nov 3;249(2):405–413. doi: 10.1016/0008-6215(93)84104-e. [DOI] [PubMed] [Google Scholar]
  75. Cherniak R. Soluble polysaccharides of Cryptococcus neoformans. Curr Top Med Mycol. 1988;2:40–54. doi: 10.1007/978-1-4612-3730-3_2. [DOI] [PubMed] [Google Scholar]
  76. Cherniak R., Sundstrom J. B. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun. 1994 May;62(5):1507–1512. doi: 10.1128/iai.62.5.1507-1512.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Christoph I. Pulmonary Cryptococcus neoformans and disseminated Nocardia brasiliensis in an immunocompromised host. Case report. N C Med J. 1990 May;51(5):219–220. [PubMed] [Google Scholar]
  78. Chuck S. L., Sande M. A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med. 1989 Sep 21;321(12):794–799. doi: 10.1056/NEJM198909213211205. [DOI] [PubMed] [Google Scholar]
  79. Cimetidine and common variable hypogammaglobulinemia. N Engl J Med. 1985 Jul 25;313(4):264–266. doi: 10.1056/NEJM198507253130413. [DOI] [PubMed] [Google Scholar]
  80. Clark J. M., Whitney R. R., Olsen S. J., George R. J., Swerdel M. R., Kunselman L., Bonner D. P. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother. 1991 Apr;35(4):615–621. doi: 10.1128/aac.35.4.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Clark R. A., Greer D. L., Valainis G. T., Hyslop N. E. Cryptococcus neoformans pulmonary infection in HIV-1-infected patients. J Acquir Immune Defic Syndr. 1990;3(5):480–484. [PubMed] [Google Scholar]
  82. Clark R. A., Greer D., Atkinson W., Valainis G. T., Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis. 1990 Sep-Oct;12(5):768–777. doi: 10.1093/clinids/12.5.768. [DOI] [PubMed] [Google Scholar]
  83. Cohen I. Isolated pulmonary cryptococcosis in a young adolescent. Pediatr Infect Dis. 1985 Jul-Aug;4(4):416–418. doi: 10.1097/00006454-198507000-00022. [DOI] [PubMed] [Google Scholar]
  84. Coker R. J., Viviani M., Gazzard B. G., Du Pont B., Pohle H. D., Murphy S. M., Atouguia J., Champalimaud J. L., Harris J. R. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS. 1993 Jun;7(6):829–835. doi: 10.1097/00002030-199306000-00011. [DOI] [PubMed] [Google Scholar]
  85. Collins H. L., Bancroft G. J. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol. 1992 Jun;22(6):1447–1454. doi: 10.1002/eji.1830220617. [DOI] [PubMed] [Google Scholar]
  86. Concus A. P., Helfand R. F., Imber M. J., Lerner E. A., Sharpe R. J. Cutaneous cryptococcosis mimicking molluscum contagiosum in a patient with AIDS. J Infect Dis. 1988 Oct;158(4):897–898. doi: 10.1093/infdis/158.4.897. [DOI] [PubMed] [Google Scholar]
  87. Cornell S. H., Jacoby C. G. The varied computed tomographic appearance of intracranial cryptococcosis. Radiology. 1982 Jun;143(3):703–707. doi: 10.1148/radiology.143.3.7079496. [DOI] [PubMed] [Google Scholar]
  88. Cox G. M., Rude T. H., Dykstra C. C., Perfect J. R. The actin gene from Cryptococcus neoformans: structure and phylogenetic analysis. J Med Vet Mycol. 1995 Jul-Aug;33(4):261–266. doi: 10.1080/02681219580000521. [DOI] [PubMed] [Google Scholar]
  89. Crowe S. M., Carlin J. B., Stewart K. I., Lucas C. R., Hoy J. F. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr. 1991;4(8):770–776. [PubMed] [Google Scholar]
  90. Crump J. R., Elner S. G., Elner V. M., Kauffman C. A. Cryptococcal endophthalmitis: case report and review. Clin Infect Dis. 1992 May;14(5):1069–1073. doi: 10.1093/clinids/14.5.1069. [DOI] [PubMed] [Google Scholar]
  91. Currie B. P., Freundlich L. F., Casadevall A. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol. 1994 May;32(5):1188–1192. doi: 10.1128/jcm.32.5.1188-1192.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Currie B. P., Freundlich L. F., Soto M. A., Casadevall A. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microbiol. 1993 Sep;31(9):2519–2522. doi: 10.1128/jcm.31.9.2519-2522.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Curtis J. L., Huffnagle G. B., Chen G. H., Warnock M. L., Gyetko M. R., McDonald R. A., Scott P. J., Toews G. B. Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab Invest. 1994 Jul;71(1):113–126. [PubMed] [Google Scholar]
  94. Dalgleish A. G. Concurrent hydatid disease and cryptococcosis in a 16-year-old girl. Med J Aust. 1981 Aug 8;2(3):144–145. doi: 10.5694/j.1326-5377.1981.tb100838.x. [DOI] [PubMed] [Google Scholar]
  95. Davies S. F., Clifford D. P., Hoidal J. R., Repine J. E. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. J Infect Dis. 1982 Jun;145(6):870–874. doi: 10.1093/infdis/145.6.870. [DOI] [PubMed] [Google Scholar]
  96. Davies S. F., Sarosi G. A. Role of serodiagnostic tests and skin tests in the diagnosis of fungal disease. Clin Chest Med. 1987 Mar;8(1):135–146. [PubMed] [Google Scholar]
  97. Denning D. W., Armstrong R. W., Fishman M., Stevens D. A. Endophthalmitis in a patient with disseminated cryptococcosis and AIDS who was treated with itraconazole. Rev Infect Dis. 1991 Nov-Dec;13(6):1126–1130. doi: 10.1093/clinids/13.6.1126. [DOI] [PubMed] [Google Scholar]
  98. Denning D. W., Armstrong R. W., Lewis B. H., Stevens D. A. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med. 1991 Sep;91(3):267–272. doi: 10.1016/0002-9343(91)90126-i. [DOI] [PubMed] [Google Scholar]
  99. Denning D. W., Follansbee S. E., Scolaro M., Norris S., Edelstein H., Stevens D. A. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991 Mar 7;324(10):654–662. doi: 10.1056/NEJM199103073241003. [DOI] [PubMed] [Google Scholar]
  100. Denning D. W., Stevens D. A., Hamilton J. R. Comparison of Guizotia abyssinica seed extract (birdseed) agar with conventional media for selective identification of Cryptococcus neoformans in patients with acquired immunodeficiency syndrome. J Clin Microbiol. 1990 Nov;28(11):2565–2567. doi: 10.1128/jcm.28.11.2565-2567.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Denning D. W., Tucker R. M., Hanson L. H., Hamilton J. R., Stevens D. A. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med. 1989 Oct;149(10):2301–2308. [PubMed] [Google Scholar]
  102. Desmet P., Kayembe K. D., De Vroey C. The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire. AIDS. 1989 Feb;3(2):77–78. doi: 10.1097/00002030-198902000-00004. [DOI] [PubMed] [Google Scholar]
  103. Devi S. J., Schneerson R., Egan W., Ulrich T. J., Bryla D., Robbins J. B., Bennett J. E. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun. 1991 Oct;59(10):3700–3707. doi: 10.1128/iai.59.10.3700-3707.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. DiRita V. J. Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae. Mol Microbiol. 1992 Feb;6(4):451–458. doi: 10.1111/j.1365-2958.1992.tb01489.x. [DOI] [PubMed] [Google Scholar]
  105. Diamond R. D. Antibody-dependent killing of Cryptococcus neopormans by human peripheral blood mononuclear cells. Nature. 1974 Jan 18;247(5437):148–150. doi: 10.1038/247148a0. [DOI] [PubMed] [Google Scholar]
  106. Diamond R. D., Bennett J. E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974 Feb;80(2):176–181. doi: 10.7326/0003-4819-80-2-176. [DOI] [PubMed] [Google Scholar]
  107. Diamond R. D. Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis. Infect Immun. 1977 Jul;17(1):187–194. doi: 10.1128/iai.17.1.187-194.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Diamond R. D., May J. E., Kane M. A., Frank M. M., Bennett J. E. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol. 1974 Jun;112(6):2260–2270. [PubMed] [Google Scholar]
  109. Diamond R. D., Root R. K., Bennett J. E. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis. 1972 Apr;125(4):367–376. doi: 10.1093/infdis/125.4.367. [DOI] [PubMed] [Google Scholar]
  110. Dismukes W. E., Cloud G., Gallis H. A., Kerkering T. M., Medoff G., Craven P. C., Kaplowitz L. G., Fisher J. F., Gregg C. R., Bowles C. A. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987 Aug 6;317(6):334–341. doi: 10.1056/NEJM198708063170602. [DOI] [PubMed] [Google Scholar]
  111. Dismukes W. E. Cryptococcal meningitis in patients with AIDS. J Infect Dis. 1988 Apr;157(4):624–628. doi: 10.1093/infdis/157.4.624. [DOI] [PubMed] [Google Scholar]
  112. Dismukes W. E. Management of cryptococcosis. Clin Infect Dis. 1993 Nov;17 (Suppl 2):S507–S512. doi: 10.1093/clinids/17.supplement_2.s507. [DOI] [PubMed] [Google Scholar]
  113. Dismukes W. E., Stamm A. M., Graybill J. R., Craven P. C., Stevens D. A., Stiller R. L., Sarosi G. A., Medoff G., Gregg C. R., Gallis H. A. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med. 1983 Jan;98(1):13–20. doi: 10.7326/0003-4819-98-1-13. [DOI] [PubMed] [Google Scholar]
  114. Doft B. H., Curtin V. T. Combined ocular infection with cytomegalovirus and cryptococcosis. Arch Ophthalmol. 1982 Nov;100(11):1800–1803. doi: 10.1001/archopht.1982.01030040780014. [DOI] [PubMed] [Google Scholar]
  115. Dromer F., Charreire J., Contrepois A., Carbon C., Yeni P. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun. 1987 Mar;55(3):749–752. doi: 10.1128/iai.55.3.749-752.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Dromer F., Charreire J. Improved amphotericin B activity by a monoclonal anti-Cryptococcus neoformans antibody: study during murine cryptococcosis and mechanisms of action. J Infect Dis. 1991 May;163(5):1114–1120. doi: 10.1093/infdis/163.5.1114. [DOI] [PubMed] [Google Scholar]
  117. Dromer F., Gueho E., Ronin O., Dupont B. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J Clin Microbiol. 1993 Feb;31(2):359–363. doi: 10.1128/jcm.31.2.359-363.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Dromer F., Perronne C., Barge J., Vilde J. L., Yeni P. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis. Clin Exp Immunol. 1989 Dec;78(3):412–417. [PMC free article] [PubMed] [Google Scholar]
  119. Dromer F., Varma A., Ronin O., Mathoulin S., Dupont B. Molecular typing of Cryptococcus neoformans serotype D clinical isolates. J Clin Microbiol. 1994 Oct;32(10):2364–2371. doi: 10.1128/jcm.32.10.2364-2371.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Dromer F., Yeni P., Charreire J. Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice. Immunogenetics. 1988;28(6):417–424. doi: 10.1007/BF00355373. [DOI] [PubMed] [Google Scholar]
  121. Duperval R., Hermans P. E., Brewer N. S., Roberts G. D. Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract. Chest. 1977 Jul;72(1):13–19. doi: 10.1378/chest.72.1.13. [DOI] [PubMed] [Google Scholar]
  122. Dupont B., Drouhet E. Cryptococcal meningitis and fluconazole. Ann Intern Med. 1987 May;106(5):778–778. doi: 10.7326/0003-4819-106-5-778_2. [DOI] [PubMed] [Google Scholar]
  123. Dykstra M. A., Friedman L., Murphy J. W. Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect Immun. 1977 Apr;16(1):129–135. doi: 10.1128/iai.16.1.129-135.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. EMMONS C. W. Isolation of Cryptococcus neoformans from soil. J Bacteriol. 1951 Dec;62(6):685–690. doi: 10.1128/jb.62.6.685-690.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. EMMONS C. W. Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia). Am J Hyg. 1955 Nov;62(3):227–232. doi: 10.1093/oxfordjournals.aje.a119775. [DOI] [PubMed] [Google Scholar]
  126. EVANS E. E. An immunologic comparison of 12 strains of Cryptococcus neoformans (Torula histolytica). Proc Soc Exp Biol Med. 1949 Aug;71(4):644–646. doi: 10.3181/00379727-71-17283. [DOI] [PubMed] [Google Scholar]
  127. EVANS E. E., KESSEL J. F. The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharide. J Immunol. 1951 Aug;67(2):109–114. [PubMed] [Google Scholar]
  128. EVANS E. E. The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J Immunol. 1950 May;64(5):423–430. [PubMed] [Google Scholar]
  129. Edman J. C. Isolation of telomerelike sequences from Cryptococcus neoformans and their use in high-efficiency transformation. Mol Cell Biol. 1992 Jun;12(6):2777–2783. doi: 10.1128/mcb.12.6.2777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Edman J. C., Kwon-Chung K. J. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol. 1990 Sep;10(9):4538–4544. doi: 10.1128/mcb.10.9.4538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Ellis D. H., Pfeiffer T. J. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet. 1990 Oct 13;336(8720):923–925. doi: 10.1016/0140-6736(90)92283-n. [DOI] [PubMed] [Google Scholar]
  132. Ellis D. H., Pfeiffer T. J. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol. 1990 Jul;28(7):1642–1644. doi: 10.1128/jcm.28.7.1642-1644.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Ellis D., Pfeiffer T. The ecology of Cryptococcus neoformans. Eur J Epidemiol. 1992 May;8(3):321–325. doi: 10.1007/BF00158562. [DOI] [PubMed] [Google Scholar]
  134. Eng R. H., Bishburg E., Smith S. M., Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med. 1986 Jul;81(1):19–23. doi: 10.1016/0002-9343(86)90176-2. [DOI] [PubMed] [Google Scholar]
  135. Erke K. H., Schneidau J. D., Jr Relationship of some Cryptococcus neoformans hypha-forming strains to standard strains and to other species of yeasts as determined by deoxyribonucleic acid base ratios and homologies. Infect Immun. 1973 Jun;7(6):941–948. doi: 10.1128/iai.7.6.941-948.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Espinel-Ingroff A., Kish C. W., Jr, Kerkering T. M., Fromtling R. A., Bartizal K., Galgiani J. N., Villareal K., Pfaller M. A., Gerarden T., Rinaldi M. G. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol. 1992 Dec;30(12):3138–3145. doi: 10.1128/jcm.30.12.3138-3145.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Faggi E., Gargani G., Pizzirani C., Pizzirani S., Saponetto N. Cryptococcosis in domestic mammals. Mycoses. 1993 May-Jun;36(5-6):165–170. [PubMed] [Google Scholar]
  138. Fan-Havard P., Yamaguchi E., Smith S. M., Eng R. H. Diastolic hypertension in AIDS patients with cryptococcal meningitis. Am J Med. 1992 Sep;93(3):347–348. doi: 10.1016/0002-9343(92)90245-7. [DOI] [PubMed] [Google Scholar]
  139. Farmer S. G., Komorowski R. A. Histologic response to capsule-deficient Cryptococcus neoformans. Arch Pathol. 1973 Dec;96(6):383–387. [PubMed] [Google Scholar]
  140. Feigin D. S. Pulmonary cryptococcosis: radiologic-pathologic correlates of its three forms. AJR Am J Roentgenol. 1983 Dec;141(6):1262–1272. doi: 10.2214/ajr.141.6.1262. [DOI] [PubMed] [Google Scholar]
  141. Felton F. G., Maldonado W. E., Muchmore H. G., Rhoades E. R. Experimental cryptococcal infection in rabbits. Am Rev Respir Dis. 1966 Oct;94(4):589–594. doi: 10.1164/arrd.1966.94.4.589. [DOI] [PubMed] [Google Scholar]
  142. Fink J. N., Barboriak J. J., Kaufman L. Cryptococcal antibodies in pigeon breeders' disease. J Allergy. 1968 May;41(5):297–301. doi: 10.1016/0021-8707(68)90035-x. [DOI] [PubMed] [Google Scholar]
  143. Finlay B. B., Falkow S. Common themes in microbial pathogenicity. Microbiol Rev. 1989 Jun;53(2):210–230. doi: 10.1128/mr.53.2.210-230.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Flesch I. E., Schwamberger G., Kaufmann S. H. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol. 1989 May 1;142(9):3219–3224. [PubMed] [Google Scholar]
  145. Fouret P., Roux P., Touboul J. L., Lancastre F., Roland J. Diagnostic rapide d'une cryptococcose pulmonaire par examen cytologique du liquide de lavage broncho-alvéolaire (LBA). Arch Anat Cytol Pathol. 1985;33(2):90–92. [PubMed] [Google Scholar]
  146. Frank U. K., Nishimura S. L., Li N. C., Sugai K., Yajko D. M., Hadley W. K., Ng V. L. Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid. J Clin Microbiol. 1993 Jan;31(1):97–101. doi: 10.1128/jcm.31.1.97-101.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Fromtling R. A., Abruzzo G. K., Bulmer G. S. Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC. Mycopathologia. 1986 Apr;94(1):27–30. doi: 10.1007/BF00437258. [DOI] [PubMed] [Google Scholar]
  148. Fromtling R. A., Galgiani J. N., Pfaller M. A., Espinel-Ingroff A., Bartizal K. F., Bartlett M. S., Body B. A., Frey C., Hall G., Roberts G. D. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother. 1993 Jan;37(1):39–45. doi: 10.1128/aac.37.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Fromtling R. A., Shadomy H. J., Jacobson E. S. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia. 1982 Jul 23;79(1):23–29. doi: 10.1007/BF00636177. [DOI] [PubMed] [Google Scholar]
  150. Fujita N. K., Reynard M., Sapico F. L., Guze L. B., Edwards J. E., Jr Cryptococcal intracerebral mass lesions: the role of computed tomography and nonsurgical management. Ann Intern Med. 1981 Mar;94(3):382–388. doi: 10.7326/0003-4819-94-3-382. [DOI] [PubMed] [Google Scholar]
  151. GOSLING H. R., GILMER W. S., Jr Skeletal cryptococcosis (torulosis); report of a case and review of the literature. J Bone Joint Surg Am. 1956 Jun;38-A(3):660–668. [PubMed] [Google Scholar]
  152. Gade W., Hinnefeld S. W., Babcock L. S., Gilligan P., Kelly W., Wait K., Greer D., Pinilla M., Kaplan R. L. Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens. J Clin Microbiol. 1991 Aug;29(8):1616–1619. doi: 10.1128/jcm.29.8.1616-1619.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Gal A. A., Koss M. N., Hawkins J., Evans S., Einstein H. The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1986 Jun;110(6):502–507. [PubMed] [Google Scholar]
  154. Gallis H. A., Berman R. A., Cate T. R., Hamilton J. D., Gunnells J. C., Stickel D. L. Fungal infection following renal transplantation. Arch Intern Med. 1975 Sep;135(9):1163–1172. [PubMed] [Google Scholar]
  155. Garcia C. A., Weisberg L. A., Lacorte W. S. Cryptococcal intracerebral mass lesions: CT-pathologic considerations. Neurology. 1985 May;35(5):731–734. doi: 10.1212/wnl.35.5.731. [DOI] [PubMed] [Google Scholar]
  156. Gauder J. P. Cryptococcal cellulitis. JAMA. 1977 Feb 14;237(7):672–673. [PubMed] [Google Scholar]
  157. Gerstenhaber B. J., Weiner B., Morecki R., Bernstein R., Luftschein S. "Allergic" cryptococcal pneumonia. Lung. 1977;154(3):195–199. [PubMed] [Google Scholar]
  158. Ghannoum M. A., Ibrahim A. S., Fu Y., Shafiq M. C., Edwards J. E., Jr, Criddle R. S. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol. 1992 Nov;30(11):2881–2886. doi: 10.1128/jcm.30.11.2881-2886.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Goldberg M. B., Boyko S. A., Calderwood S. B. Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1125–1129. doi: 10.1073/pnas.88.4.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Goldberg M. B., Boyko S. A., Calderwood S. B. Transcriptional regulation by iron of a Vibrio cholerae virulence gene and homology of the gene to the Escherichia coli fur system. J Bacteriol. 1990 Dec;172(12):6863–6870. doi: 10.1128/jb.172.12.6863-6870.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Goldman D., Lee S. C., Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun. 1994 Nov;62(11):4755–4761. doi: 10.1128/iai.62.11.4755-4761.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Gordon M. A., Lapa E. W. Elimination of rheumatoid factor in the latex test for cryptococcosis. Am J Clin Pathol. 1974 Apr;61(4):488–494. doi: 10.1093/ajcp/61.4.488. [DOI] [PubMed] [Google Scholar]
  163. Gordon M. A., Lapa E. Charcoal particle agglutination test for detection of antibody to Cryptococcus neoformans: a preliminary report. Am J Clin Pathol. 1971 Sep;56(3):354–359. doi: 10.1093/ajcp/56.3.354. [DOI] [PubMed] [Google Scholar]
  164. Gordon M. A., Vedder D. K. Serologic tests in diagnosis and prognosis of cryptococcosis. JAMA. 1966 Sep 19;197(12):961–967. [PubMed] [Google Scholar]
  165. Goren M. B., Middlebrook G. M. Protein conjugates of polysaccharide from Cryptococcus neoforman s. J Immunol. 1967 May;98(5):901–913. [PubMed] [Google Scholar]
  166. Granger D. L., Perfect J. R., Durack D. T. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest. 1985 Aug;76(2):508–516. doi: 10.1172/JCI112000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Gray L. D., Roberts G. D. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen. J Clin Microbiol. 1988 Nov;26(11):2450–2451. doi: 10.1128/jcm.26.11.2450-2451.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Graybill J. R., Craven P. C., Taylor R. L., Williams D. M., Magee W. E. Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis. 1982 May;145(5):748–752. doi: 10.1093/infdis/145.2.748. [DOI] [PubMed] [Google Scholar]
  169. Graybill J. R., Drutz D. J. Host defense in cryptococcosis. II. Cryptococcosis in the nude mouse. Cell Immunol. 1978 Oct;40(2):263–274. doi: 10.1016/0008-8749(78)90334-9. [DOI] [PubMed] [Google Scholar]
  170. Graybill J. R., Levine H. B. Successful treatment of cryptococcal meningitis with intraventricular miconazole. Arch Intern Med. 1978 May;138(5):814–816. [PubMed] [Google Scholar]
  171. Hamilton A. J., Goodley J. Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by immune sera. J Clin Microbiol. 1993 Feb;31(2):335–339. doi: 10.1128/jcm.31.2.335-339.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Hamilton J. R., Noble A., Denning D. W., Stevens D. A. Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment. J Clin Microbiol. 1991 Feb;29(2):333–339. doi: 10.1128/jcm.29.2.333-339.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Hammerman K. J., Powell K. E., Christianson C. S., Huggin P. M., Larsh H. W., Vivas J. R., Tosh F. E. Pulmonary cryptococcosis: clinical forms and treatment. A Center for Disease Control cooperative mycoses study. Am Rev Respir Dis. 1973 Nov;108(5):1116–1123. doi: 10.1164/arrd.1973.108.5.1116. [DOI] [PubMed] [Google Scholar]
  174. Haynes K. A., Sullivan D. J., Coleman D. C., Clarke J. C., Emilianus R., Atkinson C., Cann K. J. Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting. J Clin Microbiol. 1995 Jan;33(1):99–102. doi: 10.1128/jcm.33.1.99-102.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Heelan J. S., Corpus L., Kessimian N. False-positive reactions in the latex agglutination test for Cryptococcus neoformans antigen. J Clin Microbiol. 1991 Jun;29(6):1260–1261. doi: 10.1128/jcm.29.6.1260-1261.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Henderson D. K., Bennett J. E., Huber M. A. Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. J Clin Invest. 1982 May;69(5):1185–1190. doi: 10.1172/JCI110555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Henderson D. K., Kan V. L., Bennett J. E. Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro. Clin Exp Immunol. 1986 Sep;65(3):639–646. [PMC free article] [PubMed] [Google Scholar]
  178. Henson D. J., Hill A. R. Cryptococcal pneumonia: a fulminant presentation. Am J Med Sci. 1984 Dec;288(5):221–222. doi: 10.1097/00000441-198412000-00006. [DOI] [PubMed] [Google Scholar]
  179. Hidore M. R., Murphy J. W. Natural cellular resistance of beige mice against Cryptococcus neoformans. J Immunol. 1986 Dec 1;137(11):3624–3631. [PubMed] [Google Scholar]
  180. Hill J. O. CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J Exp Med. 1992 Jun 1;175(6):1685–1695. doi: 10.1084/jem.175.6.1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Hill J. O., Harmsen A. G. Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J Exp Med. 1991 Mar 1;173(3):755–758. doi: 10.1084/jem.173.3.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Hoffmann S., Stenderup J., Mathiesen L. R. Low yield of screening for cryptococcal antigen by latex agglutination assay on serum and cerebrospinal fluid from Danish patients with AIDS or ARC. Scand J Infect Dis. 1991;23(6):697–702. doi: 10.3109/00365549109024296. [DOI] [PubMed] [Google Scholar]
  183. Hopfer R. L., Walden P., Setterquist S., Highsmith W. E. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J Med Vet Mycol. 1993;31(1):65–75. doi: 10.1080/02681219380000071. [DOI] [PubMed] [Google Scholar]
  184. Horowitz I. D., Blumberg E. A., Krevolin L. Cryptococcus albidus and mucormycosis empyema in a patient receiving hemodialysis. South Med J. 1993 Sep;86(9):1070–1072. doi: 10.1097/00007611-199309000-00022. [DOI] [PubMed] [Google Scholar]
  185. Hostetler J. S., Clemons K. V., Hanson L. H., Stevens D. A. Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis. Antimicrob Agents Chemother. 1992 Dec;36(12):2656–2660. doi: 10.1128/aac.36.12.2656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Hoy J. F., Murphy J. W., Miller G. G. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection. J Infect Dis. 1989 Jan;159(1):116–119. doi: 10.1093/infdis/159.1.116. [DOI] [PubMed] [Google Scholar]
  187. Huffnagle G. B., Lipscomb M. F., Lovchik J. A., Hoag K. A., Street N. E. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol. 1994 Jan;55(1):35–42. doi: 10.1002/jlb.55.1.35. [DOI] [PubMed] [Google Scholar]
  188. Huffnagle G. B., Yates J. L., Lipscomb M. F. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J Exp Med. 1991 Apr 1;173(4):793–800. doi: 10.1084/jem.173.4.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Huffnagle K. E., Gander R. M. Evaluation of Gen-Probe's Histoplasma capsulatum and Cryptococcus neoformans AccuProbes. J Clin Microbiol. 1993 Feb;31(2):419–421. doi: 10.1128/jcm.31.2.419-421.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Hunt K. K., Enquist R. W., Bowen T. E. Multiple pulmonary nodules with central cavitation. Chest. 1976 Apr;69(4):529–530. doi: 10.1378/chest.69.4.529. [DOI] [PubMed] [Google Scholar]
  191. Ikeda R., Shinoda T., Fukazawa Y., Kaufman L. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol. 1982 Jul;16(1):22–29. doi: 10.1128/jcm.16.1.22-29.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Ikeda R., Shinoda T., Morita T., Jacobson E. S. Characterization of a phenol oxidase from Cryptococcus neoformans var. neoformans. Microbiol Immunol. 1993;37(10):759–764. doi: 10.1111/j.1348-0421.1993.tb01702.x. [DOI] [PubMed] [Google Scholar]
  193. Ingram C. W., Haywood H. B., 3rd, Morris V. M., Allen R. L., Perfect J. R. Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases. Infect Control Hosp Epidemiol. 1993 Dec;14(12):719–722. doi: 10.1086/646675. [DOI] [PubMed] [Google Scholar]
  194. Iwata K., Yamashita T., Ohsumi M., Baba M., Naito N., Taki A., Yamada N. Comparative morphological and biological studies on the itraconazole- and ketoconazole-resistant mutants of Cryptococcus neoformans. J Med Vet Mycol. 1990;28(1):77–90. doi: 10.1080/02681219080000101. [DOI] [PubMed] [Google Scholar]
  195. Jacobson E. S., Emery H. S. Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J Bacteriol. 1991 Jan;173(1):401–403. doi: 10.1128/jb.173.1.401-403.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Jacobson E. S., Jenkins N. D., Todd J. M. Relationship between superoxide dismutase and melanin in a pathogenic fungus. Infect Immun. 1994 Sep;62(9):4085–4086. doi: 10.1128/iai.62.9.4085-4086.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Jacobson E. S., Petro M. J. Extracellular iron chelation in Cryptococcus neoformans. J Med Vet Mycol. 1987 Dec;25(6):415–418. [PubMed] [Google Scholar]
  198. Jacobson E. S., Tinnell S. B. Antioxidant function of fungal melanin. J Bacteriol. 1993 Nov;175(21):7102–7104. doi: 10.1128/jb.175.21.7102-7104.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Jacobson E. S., Vartivarian S. E. Iron assimilation in Cryptococcus neoformans. J Med Vet Mycol. 1992;30(6):443–450. [PubMed] [Google Scholar]
  200. James P. G., Cherniak R. Galactoxylomannans of Cryptococcus neoformans. Infect Immun. 1992 Mar;60(3):1084–1088. doi: 10.1128/iai.60.3.1084-1088.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Jensen W. A., Rose R. M., Hammer S. M., Karchmer A. W. Serologic diagnosis of focal pneumonia caused by Cryptococcus neoformans. Am Rev Respir Dis. 1985 Jul;132(1):189–191. doi: 10.1164/arrd.1985.132.1.189. [DOI] [PubMed] [Google Scholar]
  202. Johnston S. R., Corbett E. L., Foster O., Ash S., Cohen J. Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis. J Infect. 1992 Mar;24(2):185–189. doi: 10.1016/0163-4453(92)92954-h. [DOI] [PubMed] [Google Scholar]
  203. KENT T. H., LAYTON J. M. Massive pulmonary crytococcosis. Am J Clin Pathol. 1962 Dec;38:596–604. doi: 10.1093/ajcp/38.6.596. [DOI] [PubMed] [Google Scholar]
  204. Kabasawa K., Itagaki H., Ikeda R., Shinoda T., Kagaya K., Fukazawa Y. Evaluation of a new method for identification of Cryptococcus neoformans which uses serologic tests aided by selected biological tests. J Clin Microbiol. 1991 Dec;29(12):2873–2876. doi: 10.1128/jcm.29.12.2873-2876.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Kahn F. W., England D. M., Jones J. M. Solitary pulmonary nodule due to Cryptococcus neoformans and Mycobacterium tuberculosis. Am J Med. 1985 Apr;78(4):677–681. doi: 10.1016/0002-9343(85)90413-9. [DOI] [PubMed] [Google Scholar]
  206. Kaplan M. H., Rosen P. P., Armstrong D. Cryptococcosis in a cancer hospital: clinical and pathological correlates in forty-six patients. Cancer. 1977 May;39(5):2265–2274. doi: 10.1002/1097-0142(197705)39:5<2265::aid-cncr2820390546>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  207. Kauffman C. A., Bergman A. G., Severance P. J., McClatchey K. D. Detection of cryptococcal antigen. Comparison of two latex agglutination tests. Am J Clin Pathol. 1981 Jan;75(1):106–109. doi: 10.1093/ajcp/75.1.106. [DOI] [PubMed] [Google Scholar]
  208. Keller R. G., Pfrommer G. S., Kozel T. R. Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall. Infect Immun. 1994 Jan;62(1):215–220. doi: 10.1128/iai.62.1.215-220.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Kerkering T. M., Duma R. J., Shadomy S. The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med. 1981 May;94(5):611–616. doi: 10.7326/0003-4819-94-5-611. [DOI] [PubMed] [Google Scholar]
  210. Khardori N., Butt F., Rolston K. V. Pulmonary cryptococcosis in AIDS. Chest. 1988 Jun;93(6):1319–1320. doi: 10.1378/chest.93.6.1319-c. [DOI] [PubMed] [Google Scholar]
  211. Khoury M. B., Godwin J. D., Ravin C. E., Gallis H. A., Halvorsen R. A., Putman C. E. Thoracic cryptococcosis: immunologic competence and radiologic appearance. AJR Am J Roentgenol. 1984 May;142(5):893–896. doi: 10.2214/ajr.142.5.893. [DOI] [PubMed] [Google Scholar]
  212. Kim J. H., Perfect J. R. Infection and cyclosporine. Rev Infect Dis. 1989 Sep-Oct;11(5):677–690. doi: 10.1093/clinids/11.5.677. [DOI] [PubMed] [Google Scholar]
  213. Kirsch D. R., Whitney R. R. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect Immun. 1991 Sep;59(9):3297–3300. doi: 10.1128/iai.59.9.3297-3300.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Knight F. R. New enzyme immunoassay for detecting cryptococcal antigen. J Clin Pathol. 1992 Sep;45(9):836–837. doi: 10.1136/jcp.45.9.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Kovacs J. A., Kovacs A. A., Polis M., Wright W. C., Gill V. J., Tuazon C. U., Gelmann E. P., Lane H. C., Longfield R., Overturf G. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Oct;103(4):533–538. doi: 10.7326/0003-4819-103-4-533. [DOI] [PubMed] [Google Scholar]
  216. Kozel T. R. Activation of the complement system by the capsule of Cryptococcus neoformans. Curr Top Med Mycol. 1993;5:1–26. [PubMed] [Google Scholar]
  217. Kozel T. R., Cazin J. Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide. Infect Immun. 1971 Feb;3(2):287–294. doi: 10.1128/iai.3.2.287-294.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Kozel T. R., Gotschlich E. C. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol. 1982 Oct;129(4):1675–1680. [PubMed] [Google Scholar]
  219. Kozel T. R., Mastroianni R. P. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect Immun. 1976 Jul;14(1):62–67. doi: 10.1128/iai.14.1.62-67.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Kozel T. R., Pfrommer G. S., Guerlain A. S., Highison B. A., Highison G. J. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S436–S439. doi: 10.1093/cid/10.supplement_2.s436. [DOI] [PubMed] [Google Scholar]
  221. Kozel T. R., Pfrommer G. S., Guerlain A. S., Highison B. A., Highison G. J. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect Immun. 1988 Nov;56(11):2794–2800. doi: 10.1128/iai.56.11.2794-2800.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Kramer M., Corrado M. L., Bacci V., Carter A. C., Landesman S. H. Pulmonary cryptococcosis and Cushing's syndrome. Arch Intern Med. 1983 Nov;143(11):2179–2180. [PubMed] [Google Scholar]
  223. Kromminga R., Staib F., Thalmann U., Jautzke G., Seibold M., Hochrein H., Witt H., Bürger H. Osteomyelitis due to Cryptococcus neoformans in advanced age. Case report and review of literature. Mycoses. 1990 Apr;33(4):157–166. doi: 10.1111/myc.1990.33.4.157. [DOI] [PubMed] [Google Scholar]
  224. Kwon-Chung K. J. A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia. 1976 Jul-Aug;68(4):943–946. [PubMed] [Google Scholar]
  225. Kwon-Chung K. J., Bennett J. E. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984 Jul;120(1):123–130. doi: 10.1093/oxfordjournals.aje.a113861. [DOI] [PubMed] [Google Scholar]
  226. Kwon-Chung K. J., Edman J. C., Wickes B. L. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun. 1992 Feb;60(2):602–605. doi: 10.1128/iai.60.2.602-605.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Kwon-Chung K. J. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia. 1976 Jul-Aug;68(4):821–833. [PubMed] [Google Scholar]
  228. Kwon-Chung K. J., Polacheck I., Bennett J. E. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol. 1982 Mar;15(3):535–537. doi: 10.1128/jcm.15.3.535-537.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Kwon-Chung K. J., Polacheck I., Popkin T. J. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol. 1982 Jun;150(3):1414–1421. doi: 10.1128/jb.150.3.1414-1421.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Kwon-Chung K. J., Wickes B. L., Stockman L., Roberts G. D., Ellis D., Howard D. H. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun. 1992 May;60(5):1869–1874. doi: 10.1128/iai.60.5.1869-1874.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. LITTMAN M. L. Capsule synthesis by Cryptococcus neoformans. Trans N Y Acad Sci. 1958 May;20(7):623–648. doi: 10.1111/j.2164-0947.1958.tb00625.x. [DOI] [PubMed] [Google Scholar]
  232. LOURIA D. B., FALLON N., BROWNE H. G. The influence of cortisone on experimental fungus infections in mice. J Clin Invest. 1960 Sep;39:1435–1449. doi: 10.1172/JCI104163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Lacaz C. S., Heins-Vaccari E. M., Melo N. T., Moreno-Carvalho O. A., Sampaio M. L., Nogueira L. S., Badaró R. J., Livramento J. A. Neurocriptococose por Cryptococcus neoformans não capsulado. Arq Neuropsiquiatr. 1993 Sep;51(3):395–398. doi: 10.1590/s0004-282x1993000300019. [DOI] [PubMed] [Google Scholar]
  234. Lambertus M. W., Goetz M. B., Murthy A. R., Mathisen G. E. Complications of corticosteroid therapy in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Chest. 1990 Jul;98(1):38–43. doi: 10.1378/chest.98.1.38. [DOI] [PubMed] [Google Scholar]
  235. Laroche R., Dupont B., Touze J. E., Taelman H., Bogaerts J., Kadio A., M'Pele P., Latif A., Aubry P., Durbec J. P. Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole. J Med Vet Mycol. 1992;30(1):71–78. doi: 10.1080/02681219280000091. [DOI] [PubMed] [Google Scholar]
  236. Larsen R. A., Bozzette S. A., Jones B. E., Haghighat D., Leal M. A., Forthal D., Bauer M., Tilles J. G., McCutchan J. A., Leedom J. M. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 1994 Oct;19(4):741–745. doi: 10.1093/clinids/19.4.741. [DOI] [PubMed] [Google Scholar]
  237. Larsen R. A., Bozzette S., McCutchan J. A., Chiu J., Leal M. A., Richman D. D. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. Ann Intern Med. 1989 Jul 15;111(2):125–128. doi: 10.7326/0003-4819-111-2-125. [DOI] [PubMed] [Google Scholar]
  238. Larsen R. A., Leal M. A., Chan L. S. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med. 1990 Aug 1;113(3):183–187. doi: 10.7326/0003-4819-113-3-183. [DOI] [PubMed] [Google Scholar]
  239. Lee S. C., Dickson D. W., Brosnan C. F., Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med. 1994 Jul 1;180(1):365–369. doi: 10.1084/jem.180.1.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Lehmann P. F., Morgan R. J., Freimer E. H. Infection with Cryptococcus neoformans var. gattii leading to a pulmonary cryptococcoma and meningitis. J Infect. 1984 Nov;9(3):301–306. doi: 10.1016/s0163-4453(84)90772-2. [DOI] [PubMed] [Google Scholar]
  241. Levinson D. J., Silcox D. C., Rippon J. W., Thomsen S. Septic arthritis due to nonencapsulated Cryptococcus neoformans with coexisting sarcoidosis. Arthritis Rheum. 1974 Nov-Dec;17(6):1037–1047. doi: 10.1002/art.1780170617. [DOI] [PubMed] [Google Scholar]
  242. Levitz S. M., DiBenedetto D. J. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect Immun. 1988 Oct;56(10):2544–2551. doi: 10.1128/iai.56.10.2544-2551.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Levitz S. M., DiBenedetto D. J. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol. 1989 Jan 15;142(2):659–665. [PubMed] [Google Scholar]
  244. Levitz S. M., Dupont M. P. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. J Clin Invest. 1993 Apr;91(4):1490–1498. doi: 10.1172/JCI116354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Levitz S. M., Dupont M. P., Smail E. H. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun. 1994 Jan;62(1):194–202. doi: 10.1128/iai.62.1.194-202.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Levitz S. M., Farrell T. P. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect Immun. 1990 May;58(5):1201–1209. doi: 10.1128/iai.58.5.1201-1209.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Levitz S. M., Farrell T. P., Maziarz R. T. Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture. J Infect Dis. 1991 May;163(5):1108–1113. doi: 10.1093/infdis/163.5.1108. [DOI] [PubMed] [Google Scholar]
  248. Levitz S. M. Macrophage-Cryptococcus interactions. Immunol Ser. 1994;60:533–543. [PubMed] [Google Scholar]
  249. Levitz S. M. Overview of host defenses in fungal infections. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S37–S42. doi: 10.1093/clinids/14.supplement_1.s37. [DOI] [PubMed] [Google Scholar]
  250. Levitz S. M., Tabuni A., Wagner R., Kornfeld H., Smail E. H. Binding of unopsonized Cryptococcus neoformans by human bronchoalveolar macrophages: inhibition by a large-molecular-size serum component. J Infect Dis. 1992 Oct;166(4):866–873. doi: 10.1093/infdis/166.4.866. [DOI] [PubMed] [Google Scholar]
  251. Levitz S. M. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991 Nov-Dec;13(6):1163–1169. doi: 10.1093/clinids/13.6.1163. [DOI] [PubMed] [Google Scholar]
  252. Li A., Wu S. [An urease negative Cryptococcus neoformans]. Wei Sheng Wu Xue Bao. 1992 Feb;32(1):68–71. [PubMed] [Google Scholar]
  253. Littman M. L., Borok R. Relation of the pigeon to cryptococcosis: natural carrier state, heat resistance and survival of Cryptococcus neoformans. Mycopathol Mycol Appl. 1968 Oct 14;35(3):329–345. doi: 10.1007/BF02050749. [DOI] [PubMed] [Google Scholar]
  254. Livi L. L., Edman U., Schneider G. P., Greene P. J., Santi D. V. Cloning, expression and characterization of thymidylate synthase from Cryptococcus neoformans. Gene. 1994 Dec 15;150(2):221–226. doi: 10.1016/0378-1119(94)90430-8. [DOI] [PubMed] [Google Scholar]
  255. Lo D. Cryptococcosis in the Northern Territory. Med J Aust. 1976 Nov 27;2(22):825–825,828. doi: 10.5694/j.1326-5377.1976.tb115397.x. [DOI] [PubMed] [Google Scholar]
  256. Lodge J. K., Jackson-Machelski E., Toffaletti D. L., Perfect J. R., Gordon J. I. Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12008–12012. doi: 10.1073/pnas.91.25.12008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  257. Lodge J. K., Johnson R. L., Weinberg R. A., Gordon J. I. Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans. J Biol Chem. 1994 Jan 28;269(4):2996–3009. [PubMed] [Google Scholar]
  258. Loerinc A. M., Bottone E. J., Finkel L. J., Teirstein A. S. Primary cryptococcal pneumonia mimicking Pneumocystis carinii pneumonia in a patient with AIDS. Mt Sinai J Med. 1988 Mar;55(2):181–186. [PubMed] [Google Scholar]
  259. Long J. A., Jr, Herdt J. R., Di Chiro G., Cramer H. R. Cerebral mass lesions in torulosis demonstrated by computed tomography. J Comput Assist Tomogr. 1980 Dec;4(6):766–769. doi: 10.1097/00004728-198012000-00006. [DOI] [PubMed] [Google Scholar]
  260. Lovchik J. A., Lipscomb M. F. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans. Am J Respir Cell Mol Biol. 1993 Dec;9(6):617–627. doi: 10.1165/ajrcmb/9.6.617. [DOI] [PubMed] [Google Scholar]
  261. Lynch J. P., 3rd, Schaberg D. R., Kissner D. G., Kauffman C. A. Cryptococcus laurentii lung abscess. Am Rev Respir Dis. 1981 Jan;123(1):135–138. doi: 10.1164/arrd.1981.123.1.135. [DOI] [PubMed] [Google Scholar]
  262. MORRIS E., WOLINSKY E. LOCALIZED OSSEOUS CRYPTOCOCCOSIS. A CASE REPORT. J Bone Joint Surg Am. 1965 Jul;47:1027–1029. [PubMed] [Google Scholar]
  263. Madrenys N., De Vroey C., Raes-Wuytack C., Torres-Rodríguez J. M. Identification of the perfect state of Cryptococcus neoformans from 195 clinical isolates including 84 from AIDS patients. Mycopathologia. 1993 Aug;123(2):65–68. doi: 10.1007/BF01365081. [DOI] [PubMed] [Google Scholar]
  264. Mahan M. J., Slauch J. M., Mekalanos J. J. Selection of bacterial virulence genes that are specifically induced in host tissues. Science. 1993 Jan 29;259(5095):686–688. doi: 10.1126/science.8430319. [DOI] [PubMed] [Google Scholar]
  265. Malabonga V. M., Basti J., Kamholz S. L. Utility of bronchoscopic sampling techniques for cryptococcal disease in AIDS. Chest. 1991 Feb;99(2):370–372. doi: 10.1378/chest.99.2.370. [DOI] [PubMed] [Google Scholar]
  266. Malik R., Wigney D. I., Muir D. B., Gregory D. J., Love D. N. Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole. J Med Vet Mycol. 1992;30(2):133–144. doi: 10.1080/02681219280000181. [DOI] [PubMed] [Google Scholar]
  267. Mancianti F., Giannelli C., Bendinelli M., Poli A. Mycological findings in feline immunodeficiency virus-infected cats. J Med Vet Mycol. 1992;30(3):257–259. doi: 10.1080/02681219280000321. [DOI] [PubMed] [Google Scholar]
  268. Marquis G., Montplaisir S., Pelletier M., Mousseau S., Auger P. Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice. Infect Immun. 1985 Jan;47(1):282–287. doi: 10.1128/iai.47.1.282-287.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  269. Marquis G., Montplaisir S., Pelletier M., Mousseau S., Auger P. Genetic resistance to murine cryptococcosis: the beige mutation (Chédiak-Higashi syndrome) in mice. Infect Immun. 1985 Jan;47(1):288–293. doi: 10.1128/iai.47.1.288-293.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  270. Maurelli A. T., Hromockyj A. E., Bernardini M. L. Environmental regulation of Shigella virulence. Curr Top Microbiol Immunol. 1992;180:95–116. doi: 10.1007/978-3-642-77238-2_5. [DOI] [PubMed] [Google Scholar]
  271. Mayers D. L., Martone W. J., Mandell G. L. Cutaneous cryptococcosis mimicking gram-positive cellulitis in a renal transplant patient. South Med J. 1981 Aug;74(8):1032–1033. doi: 10.1097/00007611-198108000-00051. [DOI] [PubMed] [Google Scholar]
  272. McAllister C. K., Davis C. E., Jr, Ognibene A. J., Carpenter J. L. Cryptococcal pleuro-pulmonary disease: infection of the pleural fluid in the absence of disseminated cryptococcosis. Case report. Mil Med. 1984 Dec;149(12):684–686. [PubMed] [Google Scholar]
  273. McDonnell J. M., Hutchins G. M. Pulmonary cryptococcosis. Hum Pathol. 1985 Feb;16(2):121–128. doi: 10.1016/s0046-8177(85)80060-5. [DOI] [PubMed] [Google Scholar]
  274. McManus E. J., Jones J. M. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol. 1985 May;21(5):681–685. doi: 10.1128/jcm.21.5.681-685.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Medoff G., Kobayashi G. S., Kwan C. N., Schlessinger D., Venkov P. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). Proc Natl Acad Sci U S A. 1972 Jan;69(1):196–199. doi: 10.1073/pnas.69.1.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  276. Menon A., Rajamani R. Giant 'cryptococcoma' of the lung. Br J Dis Chest. 1976 Oct;70(4):269–272. doi: 10.1016/0007-0971(76)90043-7. [DOI] [PubMed] [Google Scholar]
  277. Merkel G. J., Scofield B. A. Conditions affecting the adherence of Cryptococcus neoformans to rat glial and lung cells in vitro. J Med Vet Mycol. 1993;31(1):55–64. [PubMed] [Google Scholar]
  278. Meyer W., Lieckfeldt E., Kuhls K., Freedman E. Z., Börner T., Mitchell T. G. DNA- and PCR-fingerprinting in fungi. EXS. 1993;67:311–320. doi: 10.1007/978-3-0348-8583-6_28. [DOI] [PubMed] [Google Scholar]
  279. Meyer W., Mitchell T. G., Freedman E. Z., Vilgalys R. Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans. J Clin Microbiol. 1993 Sep;31(9):2274–2280. doi: 10.1128/jcm.31.9.2274-2280.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. Milchgrub S., Visconti E., Avellini J. Granulomatous prostatitis induced by capsule-deficient cryptococcal infection. J Urol. 1990 Feb;143(2):365–366. doi: 10.1016/s0022-5347(17)39965-2. [DOI] [PubMed] [Google Scholar]
  281. Miller G. P. The immunology of cryptococcal disease. Semin Respir Infect. 1986 Mar;1(1):45–52. [PubMed] [Google Scholar]
  282. Miller M. F., Mitchell T. G. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun. 1991 Jan;59(1):24–28. doi: 10.1128/iai.59.1.24-28.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  283. Miller M. F., Mitchell T. G., Storkus W. J., Dawson J. R. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect Immun. 1990 Mar;58(3):639–645. doi: 10.1128/iai.58.3.639-645.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  284. Miller V. L., DiRita V. J., Mekalanos J. J. Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter. J Bacteriol. 1989 Mar;171(3):1288–1293. doi: 10.1128/jb.171.3.1288-1293.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  285. Miller W. T., Jr, Edelman J. M., Miller W. T. Cryptococcal pulmonary infection in patients with AIDS: radiographic appearance. Radiology. 1990 Jun;175(3):725–728. doi: 10.1148/radiology.175.3.2343121. [DOI] [PubMed] [Google Scholar]
  286. Mitchell D. H., Sorrell T. C. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis. 1992 May;14(5):1142–1144. doi: 10.1093/clinids/14.5.1142. [DOI] [PubMed] [Google Scholar]
  287. Mitchell T. G., Freedman E. Z., White T. J., Taylor J. W. Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans. J Clin Microbiol. 1994 Jan;32(1):253–255. doi: 10.1128/jcm.32.1.253-255.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Mitchell T. G., Sandin R. L., Bowman B. H., Meyer W., Merz W. G. Molecular mycology: DNA probes and applications of PCR technology. J Med Vet Mycol. 1994;32 (Suppl 1):351–366. doi: 10.1080/02681219480000961. [DOI] [PubMed] [Google Scholar]
  289. Mitchell T. G., White T. J., Taylor J. W. Comparison of 5.8S ribosomal DNA sequences among the basidiomycetous yeast genera Cystofilobasidium, Filobasidium and Filobasidiella. J Med Vet Mycol. 1992;30(3):207–218. [PubMed] [Google Scholar]
  290. Miyagawa T., Hamagami S., Ochi T., Osugi T., Kikui M., Takahashi H. Japanese summer-type hypersensitivity pneumonitis: studies using Cryptococcus antigen. Clin Allergy. 1982 Jul;12(4):343–354. doi: 10.1111/j.1365-2222.1982.tb02538.x. [DOI] [PubMed] [Google Scholar]
  291. Mo Y. Y., Gross D. C. Plant signal molecules activate the syrB gene, which is required for syringomycin production by Pseudomonas syringae pv. syringae. J Bacteriol. 1991 Sep;173(18):5784–5792. doi: 10.1128/jb.173.18.5784-5792.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  292. Mody C. H., Chen G. H., Jackson C., Curtis J. L., Toews G. B. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J Lab Clin Med. 1993 Jun;121(6):765–773. [PubMed] [Google Scholar]
  293. Mody C. H., Lipscomb M. F., Street N. E., Toews G. B. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol. 1990 Feb 15;144(4):1472–1477. [PubMed] [Google Scholar]
  294. Mody C. H., Paine R., 3rd, Jackson C., Chen G. H., Toews G. B. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans. J Immunol. 1994 Apr 15;152(8):3970–3979. [PubMed] [Google Scholar]
  295. Mody C. H., Toews G. B., Lipscomb M. F. Treatment of murine cryptococcosis with cyclosporin-A in normal and athymic mice. Am Rev Respir Dis. 1989 Jan;139(1):8–13. doi: 10.1164/ajrccm/139.1.8. [DOI] [PubMed] [Google Scholar]
  296. Mody C. H., Tyler C. L., Sitrin R. G., Jackson C., Toews G. B. Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol. 1991 Jul;5(1):19–26. doi: 10.1165/ajrcmb/5.1.19. [DOI] [PubMed] [Google Scholar]
  297. Moore T. D., Edman J. C. The alpha-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene. Mol Cell Biol. 1993 Mar;13(3):1962–1970. doi: 10.1128/mcb.13.3.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  298. Mukherjee J., Pirofski L. A., Scharff M. D., Casadevall A. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3636–3640. doi: 10.1073/pnas.90.8.3636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  299. Mukherjee J., Zuckier L. S., Scharff M. D., Casadevall A. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother. 1994 Mar;38(3):580–587. doi: 10.1128/aac.38.3.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  300. Mukherjee S., Lee S., Mukherjee J., Scharff M. D., Casadevall A. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect Immun. 1994 Mar;62(3):1079–1088. doi: 10.1128/iai.62.3.1079-1088.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. Murata K., Khan A., Herman P. G. Pulmonary parenchymal disease: evaluation with high-resolution CT. Radiology. 1989 Mar;170(3 Pt 1):629–635. doi: 10.1148/radiology.170.3.2916013. [DOI] [PubMed] [Google Scholar]
  302. Murphey S. A., Root R. K., Schreiber A. D. The role of antibody and complement in phagocytosis by rabbit alveolar macrophages. J Infect Dis. 1979 Dec;140(6):896–903. doi: 10.1093/infdis/140.6.896. [DOI] [PubMed] [Google Scholar]
  303. Murphy J. W., Cozad G. C. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun. 1972 Jun;5(6):896–901. doi: 10.1128/iai.5.6.896-901.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  304. Murphy J. W. Cryptococcal immunity and immunostimulation. Adv Exp Med Biol. 1992;319:225–230. doi: 10.1007/978-1-4615-3434-1_23. [DOI] [PubMed] [Google Scholar]
  305. Murphy J. W. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect Immun. 1993 Nov;61(11):4750–4759. doi: 10.1128/iai.61.11.4750-4759.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  306. Murphy J. W., Hidore M. R., Wong S. C. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J Clin Invest. 1993 Apr;91(4):1553–1566. doi: 10.1172/JCI116361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  307. Murphy J. W. Influence of cryptococcal antigens on cell-mediated immunity. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S432–S435. doi: 10.1093/cid/10.supplement_2.s432. [DOI] [PubMed] [Google Scholar]
  308. Murphy J. W., McDaniel D. O. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. J Immunol. 1982 Apr;128(4):1577–1583. [PubMed] [Google Scholar]
  309. Murphy J. W. Mechanisms of natural resistance to human pathogenic fungi. Annu Rev Microbiol. 1991;45:509–538. doi: 10.1146/annurev.mi.45.100191.002453. [DOI] [PubMed] [Google Scholar]
  310. Murphy J. W., Mosley R. L., Cherniak R., Reyes G. H., Kozel T. R., Reiss E. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun. 1988 Feb;56(2):424–431. doi: 10.1128/iai.56.2.424-431.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  311. Murphy J. W. Natural killer cells and Cryptococcus neoformans. Adv Exp Med Biol. 1993;335:269–275. doi: 10.1007/978-1-4615-2980-4_37. [DOI] [PubMed] [Google Scholar]
  312. Murray R. J., Becker P., Furth P., Criner G. J. Recovery from cryptococcemia and the adult respiratory distress syndrome in the acquired immunodeficiency syndrome. Chest. 1988 Jun;93(6):1304–1306. doi: 10.1378/chest.93.6.1304. [DOI] [PubMed] [Google Scholar]
  313. Nassar F., Brummer E., Stevens D. A. Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans. Antimicrob Agents Chemother. 1994 Sep;38(9):2162–2164. doi: 10.1128/aac.38.9.2162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  314. Neilson J. B., Fromtling R. A., Bulmer G. S. Cryptococcus neoformans: size range of infectious particles from aerosolized soil. Infect Immun. 1977 Sep;17(3):634–638. doi: 10.1128/iai.17.3.634-638.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  315. Nelson M. R., Bower M., Smith D., Reed C., Shanson D., Gazzard B. The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus. J Infect. 1990 Sep;21(2):175–181. doi: 10.1016/0163-4453(90)91727-u. [DOI] [PubMed] [Google Scholar]
  316. Newberry W. M., Jr, Walter J. E., Chandler J. W., Jr, Tosh F. E. Epidemiologic study of Cryptococcus neoformans. Ann Intern Med. 1967 Oct;67(4):724–732. doi: 10.7326/0003-4819-67-4-724. [DOI] [PubMed] [Google Scholar]
  317. Nightingale S. D., Cal S. X., Peterson D. M., Loss S. D., Gamble B. A., Watson D. A., Manzone C. P., Baker J. E., Jockusch J. D. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS. 1992 Feb;6(2):191–194. doi: 10.1097/00002030-199202000-00008. [DOI] [PubMed] [Google Scholar]
  318. Nishimura K., Miyaji M. Histopathological studies on experimental cryptococcosis in nude mice. Mycopathologia. 1979 Sep 28;68(3):145–153. doi: 10.1007/BF00578522. [DOI] [PubMed] [Google Scholar]
  319. OKUN E., BUTLER W. T. OPHTHALMOLOGIC COMPLICATIONS OF CRYPTOCOCCAL MENINGITIS. Arch Ophthalmol. 1964 Jan;71:52–57. doi: 10.1001/archopht.1964.00970010068009. [DOI] [PubMed] [Google Scholar]
  320. Ofori-Kwakye S. K., Wang A. M., Morris J. H., O'Reilly G. V., Fischer E. G., Rumbaugh C. L. Septation and focal dilatation of ventricles associated with cryptococcal meningoencephalitis. Surg Neurol. 1986 Mar;25(3):253–260. doi: 10.1016/0090-3019(86)90235-1. [DOI] [PubMed] [Google Scholar]
  321. Padhye A. A., Chakrabarti A., Chander J., Kaufman L. Cryptococcus neoformans var. gattii in India. J Med Vet Mycol. 1993;31(2):165–168. [PubMed] [Google Scholar]
  322. Paillas J., Sinico M., Vieillefond A., Blaye N. Un cas de cryptococcose pulmonaire pseudo-tumorale. Sem Hop. 1982 Nov 11;58(41):2402–2404. [PubMed] [Google Scholar]
  323. Pal M. Feline meningitis due to Cryptococcus neoformans var. neoformans and review of feline cryptococcosis. Mycoses. 1991 Jul-Aug;34(7-8):313–316. doi: 10.1111/j.1439-0507.1991.tb00666.x. [DOI] [PubMed] [Google Scholar]
  324. Parker A. R., Moore T. D., Edman J. C., Schwab J. M., Davisson V. J. Cloning, sequence analysis and expression of the gene encoding imidazole glycerol phosphate dehydratase in Cryptococcus neoformans. Gene. 1994 Jul 22;145(1):135–138. doi: 10.1016/0378-1119(94)90336-0. [DOI] [PubMed] [Google Scholar]
  325. Parsot C., Mekalanos J. J. Expression of ToxR, the transcriptional activator of the virulence factors in Vibrio cholerae, is modulated by the heat shock response. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9898–9902. doi: 10.1073/pnas.87.24.9898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  326. Paugam A., Dupouy-Camet J., Blanche P., Gangneux J. P., Tourte-Schaefer C., Sicard D. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis. 1994 Nov;19(5):975–976. doi: 10.1093/clinids/19.5.975-a. [DOI] [PubMed] [Google Scholar]
  327. Pema K., Diaz J., Guerra L. G., Nabhan D., Verghese A. Disseminated cutaneous cryptococcosis. Comparison of clinical manifestations in the pre-AIDS and AIDS eras. Arch Intern Med. 1994 May 9;154(9):1032–1034. doi: 10.1001/archinte.154.9.1032. [DOI] [PubMed] [Google Scholar]
  328. Penar P. L., Kim J., Chyatte D., Sabshin J. K. Intraventricular cryptococcal granuloma. Report of two cases. J Neurosurg. 1988 Jan;68(1):145–148. doi: 10.3171/jns.1988.68.1.0145. [DOI] [PubMed] [Google Scholar]
  329. Perfect J. R. Cryptococcosis. Infect Dis Clin North Am. 1989 Mar;3(1):77–102. [PubMed] [Google Scholar]
  330. Perfect J. R., Durack D. T. Chemotactic activity of cerebrospinal fluid in experimental cryptococcal meningitis. Sabouraudia. 1985 Feb;23(1):37–45. doi: 10.1080/00362178585380071. [DOI] [PubMed] [Google Scholar]
  331. Perfect J. R., Durack D. T. Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis. Antimicrob Agents Chemother. 1985 Dec;28(6):751–755. doi: 10.1128/aac.28.6.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  332. Perfect J. R., Durack D. T. Effects of cyclosporine in experimental cryptococcal meningitis. Infect Immun. 1985 Oct;50(1):22–26. doi: 10.1128/iai.50.1.22-26.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  333. Perfect J. R., Durack D. T., Gallis H. A. Cryptococcemia. Medicine (Baltimore) 1983 Mar;62(2):98–109. doi: 10.1097/00005792-198303000-00003. [DOI] [PubMed] [Google Scholar]
  334. Perfect J. R., Durack D. T., Hamilton J. D., Gallis H. A. Failure of ketoconazole in cryptococcal meningitis. JAMA. 1982 Jun 25;247(24):3349–3351. [PubMed] [Google Scholar]
  335. Perfect J. R., Durack D. T. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. J Infect Dis. 1982 Sep;146(3):429–435. doi: 10.1093/infdis/146.3.429. [DOI] [PubMed] [Google Scholar]
  336. Perfect J. R. Fluconazole therapy for experimental cryptococcosis and candidiasis in the rabbit. Rev Infect Dis. 1990 Mar-Apr;12 (Suppl 3):S299–S302. doi: 10.1093/clinids/12.supplement_3.s299. [DOI] [PubMed] [Google Scholar]
  337. Perfect J. R., Granger D. L., Durack D. T. Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J Infect Dis. 1987 Aug;156(2):316–323. doi: 10.1093/infdis/156.2.316. [DOI] [PubMed] [Google Scholar]
  338. Perfect J. R., Hobbs M. M., Granger D. L., Durack D. T. Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect Immun. 1988 Apr;56(4):849–854. doi: 10.1128/iai.56.4.849-854.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  339. Perfect J. R., Ketabchi N., Cox G. M., Ingram C. W., Beiser C. L. Karyotyping of Cryptococcus neoformans as an epidemiological tool. J Clin Microbiol. 1993 Dec;31(12):3305–3309. doi: 10.1128/jcm.31.12.3305-3309.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  340. Perfect J. R., Lang S. D., Durack D. T. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol. 1980 Oct;101(1):177–194. [PMC free article] [PubMed] [Google Scholar]
  341. Perfect J. R., Lang S. D., Durack D. T. Influence of agglutinating antibody in experimental cryptococcal meningitis. Br J Exp Pathol. 1981 Dec;62(6):595–599. [PMC free article] [PubMed] [Google Scholar]
  342. Perfect J. R., Magee B. B., Magee P. T. Separation of chromosomes of Cryptococcus neoformans by pulsed field gel electrophoresis. Infect Immun. 1989 Sep;57(9):2624–2627. doi: 10.1128/iai.57.9.2624-2627.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  343. Perfect J. R., Rude T. H., Penning L. M., Johnson S. A. Cloning the Cryptococcus neoformans TRP1 gene by complementation in Saccharomyces cerevisiae. Gene. 1992 Dec 1;122(1):213–217. doi: 10.1016/0378-1119(92)90053-r. [DOI] [PubMed] [Google Scholar]
  344. Perfect J. R., Savani D. V., Durack D. T. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob Agents Chemother. 1986 Apr;29(4):579–583. doi: 10.1128/aac.29.4.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  345. Perfect J. R., Savani D. V., Durack D. T. Uptake of itraconazole by alveolar macrophages. Antimicrob Agents Chemother. 1993 Apr;37(4):903–904. doi: 10.1128/aac.37.4.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  346. Perfect J. R., Seaworth B. A. Penile cryptococcosis with review of mycotic infections of penis. Urology. 1985 May;25(5):528–531. doi: 10.1016/0090-4295(85)90469-8. [DOI] [PubMed] [Google Scholar]
  347. Perfect J. R., Toffaletti D. L., Rude T. H. The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infect Immun. 1993 Oct;61(10):4446–4451. doi: 10.1128/iai.61.10.4446-4451.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  348. Perfect J. R., Wright K. A. Amphotericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidosis. J Antimicrob Chemother. 1994 Jan;33(1):73–81. doi: 10.1093/jac/33.1.73. [DOI] [PubMed] [Google Scholar]
  349. Perfect J. R., Wright K. A., Hobbs M. M., Durack D. T. Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. Antimicrob Agents Chemother. 1989 Oct;33(10):1735–1740. doi: 10.1128/aac.33.10.1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  350. Perla E. N., Maayan S., Miller S. N., Ramaswamy G., Eisenberg H. Disseminated cryptococcosis presenting as the adult respiratory distress syndrome. N Y State J Med. 1985 Dec;85(12):704–706. [PubMed] [Google Scholar]
  351. Perry H. D., Donnenfeld E. D. Cryptococcal keratitis after keratoplasty. Am J Ophthalmol. 1990 Sep 15;110(3):320–321. doi: 10.1016/s0002-9394(14)76362-7. [DOI] [PubMed] [Google Scholar]
  352. Pettoello-Mantovani M., Casadevall A., Goldstein H. The presence of cryptococcal capsular polysaccharide increases the sensitivity of HIV-1 coculture in children. Ann N Y Acad Sci. 1993 Oct 29;693:281–283. doi: 10.1111/j.1749-6632.1993.tb26283.x. [DOI] [PubMed] [Google Scholar]
  353. Pettoello-Mantovani M., Casadevall A., Kollmann T. R., Rubinstein A., Goldstein H. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet. 1992 Jan 4;339(8784):21–23. doi: 10.1016/0140-6736(92)90142-p. [DOI] [PubMed] [Google Scholar]
  354. Pfeiffer T., Ellis D. Environmental isolation of Cryptococcus neoformans gattii from California. J Infect Dis. 1991 Apr;163(4):929–930. doi: 10.1093/infdis/163.4.929. [DOI] [PubMed] [Google Scholar]
  355. Pfrommer G. S., Dickens S. M., Wilson M. A., Young B. J., Kozel T. R. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule. Infect Immun. 1993 Oct;61(10):4360–4366. doi: 10.1128/iai.61.10.4360-4366.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  356. Piérard G. E., Piérard-Franchimont C., Estrada J. A., Rurangirwa A., Dosal F. L. Cutaneous mixed infections in AIDS. Am J Dermatopathol. 1990 Feb;12(1):63–66. doi: 10.1097/00000372-199002000-00009. [DOI] [PubMed] [Google Scholar]
  357. Plunkett J. M., Turner B. I., Tallent M. B., Johnson H. K. Cryptococcal septicemia associated with urologic instrumentation in a renal allograft recipient. J Urol. 1981 Feb;125(2):241–242. doi: 10.1016/s0022-5347(17)54987-3. [DOI] [PubMed] [Google Scholar]
  358. Polacheck I., Hearing V. J., Kwon-Chung K. J. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J Bacteriol. 1982 Jun;150(3):1212–1220. doi: 10.1128/jb.150.3.1212-1220.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  359. Polacheck I., Kwon-Chung K. J. Canavanine resistance in Cryptococcus neoformans. Antimicrob Agents Chemother. 1986 Mar;29(3):468–473. doi: 10.1128/aac.29.3.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  360. Polacheck I., Kwon-Chung K. J. Melanogenesis in Cryptococcus neoformans. J Gen Microbiol. 1988 Apr;134(4):1037–1041. doi: 10.1099/00221287-134-4-1037. [DOI] [PubMed] [Google Scholar]
  361. Polacheck I., Lebens G. A. Electrophoretic karyotype of the pathogenic yeast Cryptococcus neoformans. J Gen Microbiol. 1989 Jan;135(1):65–71. doi: 10.1099/00221287-135-1-65. [DOI] [PubMed] [Google Scholar]
  362. Polacheck I., Lebens G., Hicks J. B. Development of DNA probes for early diagnosis and epidemiological study of cryptococcosis in AIDS patients. J Clin Microbiol. 1992 Apr;30(4):925–930. doi: 10.1128/jcm.30.4.925-930.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  363. Polacheck I., Platt Y., Aronovitch J. Catecholamines and virulence of Cryptococcus neoformans. Infect Immun. 1990 Sep;58(9):2919–2922. doi: 10.1128/iai.58.9.2919-2922.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  364. Polak A. Melanin as a virulence factor in pathogenic fungi. Mycoses. 1990 May;33(5):215–224. doi: 10.1111/myc.1990.33.5.215. [DOI] [PubMed] [Google Scholar]
  365. Polak A., Scholer H. J., Wall M. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. Chemotherapy. 1982;28(6):461–479. doi: 10.1159/000238138. [DOI] [PubMed] [Google Scholar]
  366. Polsky B., Depman M. R., Gold J. W., Galicich J. H., Armstrong D. Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am J Med. 1986 Jul;81(1):24–28. doi: 10.1016/0002-9343(86)90177-4. [DOI] [PubMed] [Google Scholar]
  367. Popovich M. J., Arthur R. H., Helmer E. CT of intracranial cryptococcosis. AJR Am J Roentgenol. 1990 Mar;154(3):603–606. doi: 10.2214/ajr.154.3.2106227. [DOI] [PubMed] [Google Scholar]
  368. Powderly W. G., Cloud G. A., Dismukes W. E., Saag M. S. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1994 May;18(5):789–792. doi: 10.1093/clinids/18.5.789. [DOI] [PubMed] [Google Scholar]
  369. Powderly W. G. Cryptococcal meningitis and AIDS. Clin Infect Dis. 1993 Nov;17(5):837–842. doi: 10.1093/clinids/17.5.837. [DOI] [PubMed] [Google Scholar]
  370. Powderly W. G., Finkelstein D., Feinberg J., Frame P., He W., van der Horst C., Koletar S. L., Eyster M. E., Carey J., Waskin H. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995 Mar 16;332(11):700–705. doi: 10.1056/NEJM199503163321102. [DOI] [PubMed] [Google Scholar]
  371. Powderly W. G., Saag M. S., Cloud G. A., Robinson P., Meyer R. D., Jacobson J. M., Graybill J. R., Sugar A. M., McAuliffe V. J., Follansbee S. E. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med. 1992 Mar 19;326(12):793–798. doi: 10.1056/NEJM199203193261203. [DOI] [PubMed] [Google Scholar]
  372. Powell K. E., Dahl B. A., Weeks R. J., Tosh F. E. Airborne Cryptococcus neoformans: particles from pigeon excreta compatible with alveolar deposition. J Infect Dis. 1972 Apr;125(4):412–415. doi: 10.1093/infdis/125.4.412. [DOI] [PubMed] [Google Scholar]
  373. Pujol C., Reynes J., Renaud F., Raymond M., Tibayrenc M., Ayala F. J., Janbon F., Mallié M., Bastide J. M. The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9456–9459. doi: 10.1073/pnas.90.20.9456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  374. Reiss F., Szilagyi G., Mayer E. Immunological studies of the anticryptococcal factor of normal human serum. Mycopathologia. 1975 Jun 14;55(3):175–178. doi: 10.1007/BF00491504. [DOI] [PubMed] [Google Scholar]
  375. Restrepo B. I., Barbour A. G. Cloning of 18S and 25S rDNAs from the pathogenic fungus Cryptococcus neoformans. J Bacteriol. 1989 Oct;171(10):5596–5600. doi: 10.1128/jb.171.10.5596-5600.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  376. Rex J. H., Larsen R. A., Dismukes W. E., Cloud G. A., Bennett J. E. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine (Baltimore) 1993 Jul;72(4):207–224. doi: 10.1097/00005792-199307000-00001. [DOI] [PubMed] [Google Scholar]
  377. Rhodes J. C. Contribution of complement component C5 to the pathogenesis of experimental murine cryptococcosis. Sabouraudia. 1985 Jun;23(3):225–234. doi: 10.1080/00362178585380331. [DOI] [PubMed] [Google Scholar]
  378. Rhodes J. C., Polacheck I., Kwon-Chung K. J. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun. 1982 Jun;36(3):1175–1184. doi: 10.1128/iai.36.3.1175-1184.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  379. Rhodes J. C., Wicker L. S., Urba W. J. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect Immun. 1980 Aug;29(2):494–499. doi: 10.1128/iai.29.2.494-499.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  380. Riley E., Cahan W. G. Pulmonary cryptocococcis followed by pulmonary tuberculosis. A case report. Am Rev Respir Dis. 1972 Oct;106(4):594–599. doi: 10.1164/arrd.1972.106.4.594. [DOI] [PubMed] [Google Scholar]
  381. Roilides E., Holmes A., Blake C., Pizzo P. A., Walsh T. J. Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus. J Infect Dis. 1993 Dec;168(6):1562–1565. doi: 10.1093/infdis/168.6.1562. [DOI] [PubMed] [Google Scholar]
  382. Rosenheim S. H., Schwarz J. Cavitary pulmonary cryptococcosis complicated by aspergilloma. Am Rev Respir Dis. 1975 Apr;111(4):549–553. doi: 10.1164/arrd.1975.111.4.549. [DOI] [PubMed] [Google Scholar]
  383. Rozenbaum R., Gonçalves A. J. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis. 1994 Mar;18(3):369–380. doi: 10.1093/clinids/18.3.369. [DOI] [PubMed] [Google Scholar]
  384. Rubinstein H., Marticorena B., Masih D., Borletto N., Vega R., Varengo H., Negroni R. Isolation of human fungi from soil and identification of two endemic areas of Cryptococcus neoformans and Coccidioides immitis. Rev Inst Med Trop Sao Paulo. 1989 Jan-Feb;31(1):1–6. doi: 10.1590/s0036-46651989000100001. [DOI] [PubMed] [Google Scholar]
  385. Ruiz A., Bulmer G. S. Particle size of airborn Cryptococcus neoformans in a tower. Appl Environ Microbiol. 1981 May;41(5):1225–1229. doi: 10.1128/aem.41.5.1225-1229.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  386. Saag M. S., Powderly W. G., Cloud G. A., Robinson P., Grieco M. H., Sharkey P. K., Thompson S. E., Sugar A. M., Tuazon C. U., Fisher J. F. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992 Jan 9;326(2):83–89. doi: 10.1056/NEJM199201093260202. [DOI] [PubMed] [Google Scholar]
  387. Sakai T., Sasakawa C., Makino S., Yoshikawa M. DNA sequence and product analysis of the virF locus responsible for congo red binding and cell invasion in Shigella flexneri 2a. Infect Immun. 1986 Nov;54(2):395–402. doi: 10.1128/iai.54.2.395-402.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  388. Salkowski C. A., Balish E. Cryptococcosis in beige mice: the effect of congenital defects in innate immunity on susceptibility. Can J Microbiol. 1991 Feb;37(2):128–135. doi: 10.1139/m91-019. [DOI] [PubMed] [Google Scholar]
  389. Salkowski C. A., Balish E. Cutaneous cryptococcosis in athymic and beige-athymic mice. Infect Immun. 1991 May;59(5):1785–1789. doi: 10.1128/iai.59.5.1785-1789.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  390. Salkowski C. A., Balish E. Inflammatory responses to cryptococcosis in congenitally athymic mice. J Leukoc Biol. 1991 Jun;49(6):533–541. doi: 10.1002/jlb.49.6.533. [DOI] [PubMed] [Google Scholar]
  391. Salkowski C. A., Balish E. Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice. Infect Immun. 1990 Oct;58(10):3300–3306. doi: 10.1128/iai.58.10.3300-3306.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  392. Salkowski C. A., Bartizal K. F., Balish M. J., Balish E. Colonization and pathogenesis of Cryptococcus neoformans in gnotobiotic mice. Infect Immun. 1987 Sep;55(9):2000–2005. doi: 10.1128/iai.55.9.2000-2005.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  393. Sarosi G. A., Parker J. D., Doto I. L., Tosh F. E. Amphotericin B in cryptococcal meningitis. Long-term results of treatment. Ann Intern Med. 1969 Dec;71(6):1079–1087. doi: 10.7326/0003-4819-71-6-1079. [DOI] [PubMed] [Google Scholar]
  394. Sarosi G. A., Silberfarb P. M., Tosh F. E. Cutaneous cryptococcosis. A sentinel of disseminated disease. Arch Dermatol. 1971 Jul;104(1):1–3. doi: 10.1001/archderm.104.1.1. [DOI] [PubMed] [Google Scholar]
  395. Schröter G. P., Temple D. R., Husberg B. S., Weil R., 3rd, Starzl T. E. Cryptococcosis after renal transplantation: report of ten cases. Surgery. 1976 Mar;79(3):268–277. [PMC free article] [PubMed] [Google Scholar]
  396. Schupbach C. W., Wheeler C. E., Jr, Briggaman R. A., Warner N. A., Kanof E. P. Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol. 1976 Dec;112(12):1734–1740. [PubMed] [Google Scholar]
  397. Schønheyder H., Thestrup-Pedersen K., Esmann V., Stenderup A. Cryptococcal meningitis: complications due to intrathecal treatment. Scand J Infect Dis. 1980;12(2):155–157. doi: 10.3109/inf.1980.12.issue-2.16. [DOI] [PubMed] [Google Scholar]
  398. Shadomy H. J., Wood-Helie S., Shadomy S., Dismukes W. E., Chau R. Y. Biochemical serogrouping of clinical isolates of Cryptococcus neoformans. Diagn Microbiol Infect Dis. 1987 Feb;6(2):131–138. doi: 10.1016/0732-8893(87)90097-6. [DOI] [PubMed] [Google Scholar]
  399. Shimizu R. Y., Howard D. H., Clancy M. N. The variety of Cryptococcus neoformans in patients with AIDS. J Infect Dis. 1986 Dec;154(6):1042–1042. doi: 10.1093/infdis/154.6.1042. [DOI] [PubMed] [Google Scholar]
  400. Similowski T., Datry A., Jais P., Katlama C., Rosenheim M., Gentilini M. AIDS-associated Cryptococcosis causing adult respiratory distress syndrome. Respir Med. 1989 Nov;83(6):513–515. doi: 10.1016/s0954-6111(89)80138-6. [DOI] [PubMed] [Google Scholar]
  401. Sirawaraporn W., Cao M., Santi D. V., Edman J. C. Cloning, expression, and characterization of Cryptococcus neoformans dihydrofolate reductase. J Biol Chem. 1993 Apr 25;268(12):8888–8892. [PubMed] [Google Scholar]
  402. Small J. M., Mitchell T. G. Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants. Infect Immun. 1986 Dec;54(3):742–750. doi: 10.1128/iai.54.3.742-750.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  403. Small J. M., Mitchell T. G. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infect Immun. 1989 Dec;57(12):3751–3756. doi: 10.1128/iai.57.12.3751-3756.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  404. Small J. M., Mitchell T. G., Wheat R. W. Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A. Infect Immun. 1986 Dec;54(3):735–741. doi: 10.1128/iai.54.3.735-741.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  405. Smith F. S., Gibson P., Nicholls T. T., Simpson J. A. Pulmonary resection for localized lesions of cryptococcosis (torulosis): a review of eight cases. Thorax. 1976 Apr;31(2):121–126. doi: 10.1136/thx.31.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  406. Sobonya R. E., Barbee R. A., Wiens J., Trego D. Detection of fungi and other pathogens in immunocompromised patients by bronchoalveolar lavage in an area endemic for coccidioidomycosis. Chest. 1990 Jun;97(6):1349–1355. doi: 10.1378/chest.97.6.1349. [DOI] [PubMed] [Google Scholar]
  407. Spiropulu C., Eppard R. A., Otteson E., Kozel T. R. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide. Infect Immun. 1989 Oct;57(10):3240–3242. doi: 10.1128/iai.57.10.3240-3242.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  408. Spitzer E. D., Spitzer S. G., Freundlich L. F., Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet. 1993 Mar 6;341(8845):595–596. doi: 10.1016/0140-6736(93)90354-j. [DOI] [PubMed] [Google Scholar]
  409. Spitzer E. D., Spitzer S. G. Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J Clin Microbiol. 1992 May;30(5):1094–1097. doi: 10.1128/jcm.30.5.1094-1097.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  410. Spitzer S. G., Spitzer E. D. Characterization of the CNRE-1 family of repetitive DNA elements in Cryptococcus neoformans. Gene. 1994 Jun 24;144(1):103–106. doi: 10.1016/0378-1119(94)90211-9. [DOI] [PubMed] [Google Scholar]
  411. St Germain G., Beauchesne D. Evaluation of the MicroScan Rapid Yeast Identification panel. J Clin Microbiol. 1991 Oct;29(10):2296–2299. doi: 10.1128/jcm.29.10.2296-2299.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  412. Staib F., Seibold M., L'age M., Heise W., Skörde J., Grosse G., Nürnberger F., Bauer G. Cryptococcus neoformans in the seminal fluid of an AIDS patient. A contribution to the clinical course of cryptococcosis. Mycoses. 1989 Apr;32(4):171–180. doi: 10.1111/j.1439-0507.1989.tb02227.x. [DOI] [PubMed] [Google Scholar]
  413. Stamm A. M., Diasio R. B., Dismukes W. E., Shadomy S., Cloud G. A., Bowles C. A., Karam G. H., Espinel-Ingroff A. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med. 1987 Aug;83(2):236–242. doi: 10.1016/0002-9343(87)90691-7. [DOI] [PubMed] [Google Scholar]
  414. Stansell J. D. Pulmonary fungal infections in HIV-infected persons. Semin Respir Infect. 1993 Jun;8(2):116–123. [PubMed] [Google Scholar]
  415. Stern J. J., Hartman B. J., Sharkey P., Rowland V., Squires K. E., Murray H. W., Graybill J. R. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am J Med. 1988 Oct;85(4):477–480. doi: 10.1016/s0002-9343(88)80081-0. [DOI] [PubMed] [Google Scholar]
  416. Stibitz S., Aaronson W., Monack D., Falkow S. Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system. Nature. 1989 Mar 16;338(6212):266–269. doi: 10.1038/338266a0. [DOI] [PubMed] [Google Scholar]
  417. Storz G., Tartaglia L. A., Ames B. N. Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation. Science. 1990 Apr 13;248(4952):189–194. doi: 10.1126/science.2183352. [DOI] [PubMed] [Google Scholar]
  418. Subramanian S., Kherdekar S. S., Babu P. G., Christianson C. S. Lipoid pneumonia with Cryptococcus neoformans colonisation. Thorax. 1982 Apr;37(4):319–320. doi: 10.1136/thx.37.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  419. Sundstrom J. B., Cherniak R. T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A. Infect Immun. 1993 Apr;61(4):1340–1345. doi: 10.1128/iai.61.4.1340-1345.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  420. Sundstrom J. B., Cherniak R. The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen. Infect Immun. 1992 Oct;60(10):4080–4087. doi: 10.1128/iai.60.10.4080-4087.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  421. Sung J. P., Campbell G. D., Grendahl J. G. Miconazole therapy for fungal meningitis. Arch Neurol. 1978 Jul;35(7):443–447. doi: 10.1001/archneur.1978.00500310045009. [DOI] [PubMed] [Google Scholar]
  422. Suster B., Akerman M., Orenstein M., Wax M. R. Pulmonary manifestations of AIDS: review of 106 episodes. Radiology. 1986 Oct;161(1):87–93. doi: 10.1148/radiology.161.1.3489955. [DOI] [PubMed] [Google Scholar]
  423. Swinne D., Deppner M., Laroche R., Floch J. J., Kadende P. Isolation of Cryptococcus neoformans from houses of AIDS-associated cryptococcosis patients in Bujumbura (Burundi). AIDS. 1989 Jun;3(6):389–390. doi: 10.1097/00002030-198906000-00009. [DOI] [PubMed] [Google Scholar]
  424. Taelman H., Bogaerts J., Batungwanayo J., Van de Perre P., Lucas S., Allen S. Failure of the cryptococcal serum antigen test to detect primary pulmonary cryptococcosis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1994 Jan;18(1):119–120. doi: 10.1093/clinids/18.1.119. [DOI] [PubMed] [Google Scholar]
  425. Takeo K., Tanaka R., Taguchi H., Nishimura K. Analysis of ploidy and sexual characteristics of natural isolates of Cryptococcus neoformans. Can J Microbiol. 1993 Oct;39(10):958–963. doi: 10.1139/m93-144. [DOI] [PubMed] [Google Scholar]
  426. Tan C. T., Kuan B. B. Cryptococcus meningitis, clinical--CT scan considerations. Neuroradiology. 1987;29(1):43–46. doi: 10.1007/BF00341036. [DOI] [PubMed] [Google Scholar]
  427. Tanner D. C., Weinstein M. P., Fedorciw B., Joho K. L., Thorpe J. J., Reller L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol. 1994 Jul;32(7):1680–1684. doi: 10.1128/jcm.32.7.1680-1684.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  428. Tarrand J. J., Guillot C., Wenglar M., Jackson J., Lajeunesse J. D., Rolston K. V. Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol. 1991 Oct;29(10):2245–2249. doi: 10.1128/jcm.29.10.2245-2249.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  429. Tobe T., Nagai S., Okada N., Adler B., Yoshikawa M., Sasakawa C. Temperature-regulated expression of invasion genes in Shigella flexneri is controlled through the transcriptional activation of the virB gene on the large plasmid. Mol Microbiol. 1991 Apr;5(4):887–893. doi: 10.1111/j.1365-2958.1991.tb00762.x. [DOI] [PubMed] [Google Scholar]
  430. Todaro-Luck F., Reiss E., Cherniak R., Kaufman L. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect Immun. 1989 Dec;57(12):3882–3887. doi: 10.1128/iai.57.12.3882-3887.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  431. Toffaletti D. L., Rude T. H., Johnston S. A., Durack D. T., Perfect J. R. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol. 1993 Mar;175(5):1405–1411. doi: 10.1128/jb.175.5.1405-1411.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  432. Tolkacheva T., McNamara P., Piekarz E., Courchesne W. Cloning of a Cryptococcus neoformans gene, GPA1, encoding a G-protein alpha-subunit homolog. Infect Immun. 1994 Jul;62(7):2849–2856. doi: 10.1128/iai.62.7.2849-2856.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  433. Town G. I., Seeman R. Pulmonary cryptococcosis: a report of two cases and review of the literature. N Z Med J. 1985 Oct 23;98(789):894–895. [PubMed] [Google Scholar]
  434. Turner S. H., Cherniak R. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy. Carbohydr Res. 1991 Apr 2;211(1):103–116. doi: 10.1016/0008-6215(91)84149-9. [DOI] [PubMed] [Google Scholar]
  435. Turner S. H., Cherniak R., Reiss E., Kwon-Chung K. J. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy. Carbohydr Res. 1992 Sep 2;233:205–218. doi: 10.1016/s0008-6215(00)90932-7. [DOI] [PubMed] [Google Scholar]
  436. Tynes B., Mason K. N., Jennings A. E., Bennett J. E. Variant forms of pulmonary cryptococcosis. Ann Intern Med. 1968 Dec;69(6):1117–1125. doi: 10.7326/0003-4819-69-6-1117. [DOI] [PubMed] [Google Scholar]
  437. Utz J. P. Flucytosine. N Engl J Med. 1972 Apr 6;286(14):777–778. doi: 10.1056/NEJM197204062861412. [DOI] [PubMed] [Google Scholar]
  438. Utz J. P., Garriques I. L., Sande M. A., Warner J. F., Mandell G. L., McGehee R. F., Duma R. J., Shadomy S. Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis. 1975 Oct;132(4):368–373. doi: 10.1093/infdis/132.4.368. [DOI] [PubMed] [Google Scholar]
  439. Van Cutsem J., Van Gerven F., Janssen P. A. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis. 1987 Jan-Feb;9 (Suppl 1):S15–S32. doi: 10.1093/clinids/9.supplement_1.s15. [DOI] [PubMed] [Google Scholar]
  440. Varma A., Edman J. C., Kwon-Chung K. J. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect Immun. 1992 Mar;60(3):1101–1108. doi: 10.1128/iai.60.3.1101-1108.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  441. Varma A., Kwon-Chung K. J. DNA probe for strain typing of Cryptococcus neoformans. J Clin Microbiol. 1992 Nov;30(11):2960–2967. doi: 10.1128/jcm.30.11.2960-2967.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  442. Varma A., Kwon-Chung K. J. Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans. J Gen Microbiol. 1989 Dec;135(12):3353–3362. doi: 10.1099/00221287-135-12-3353. [DOI] [PubMed] [Google Scholar]
  443. Vartivarian S. E., Anaissie E. J., Cowart R. E., Sprigg H. A., Tingler M. J., Jacobson E. S. Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis. 1993 Jan;167(1):186–190. doi: 10.1093/infdis/167.1.186. [DOI] [PubMed] [Google Scholar]
  444. Velez J. D., Allendoerfer R., Luther M., Rinaldi M. G., Graybill J. R. Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. J Infect Dis. 1993 Aug;168(2):508–510. doi: 10.1093/infdis/168.2.508. [DOI] [PubMed] [Google Scholar]
  445. Vilgalys R., Hester M. Rapid genetic identification and mapping of enzymatically amplified ribosomal DNA from several Cryptococcus species. J Bacteriol. 1990 Aug;172(8):4238–4246. doi: 10.1128/jb.172.8.4238-4246.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  446. Villanueva E., Mendoza M., Torres E., de Albornoz M. B., Cavazza M. E., Urbina G. Serotipificación de 27 cepas de Cryptococcus neoformans aisladas en Venezuela. Acta Cient Venez. 1989;40(2):151–154. [PubMed] [Google Scholar]
  447. Viviani M. A., Tortorano A. M., Giani P. C., Arici C., Goglio A., Crocchiolo P., Almaviva M. Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Jan;106(1):166–166. doi: 10.7326/0003-4819-106-1-166_1. [DOI] [PubMed] [Google Scholar]
  448. Viviani M. A., Tortorano A. M., Langer M., Almaviva M., Negri C., Cristina S., Scoccia S., De Maria R., Fiocchi R., Ferrazzi P. Experience with itraconazole in cryptococcosis and aspergillosis. J Infect. 1989 Mar;18(2):151–165. doi: 10.1016/s0163-4453(89)91178-x. [DOI] [PubMed] [Google Scholar]
  449. Viviani M. A., Tortorano A. M., Woenstenborghs R., Cauwenbergh G. Experience with itraconazole in deep mycoses in northern Italy. Mykosen. 1987 May;30(5):233–244. doi: 10.1111/j.1439-0507.1987.tb03973.x. [DOI] [PubMed] [Google Scholar]
  450. Vogel R. A. The indirect fluorescent antibody test for the detection of antibody in human cryptococcal disease. J Infect Dis. 1966 Dec;116(5):573–580. doi: 10.1093/infdis/116.5.573. [DOI] [PubMed] [Google Scholar]
  451. Wagner R. P., Levitz S. M., Tabuni A., Kornfeld H. HIV-1 envelope protein (gp120) inhibits the activity of human bronchoalveolar macrophages against Cryptococcus neoformans. Am Rev Respir Dis. 1992 Dec;146(6):1434–1438. doi: 10.1164/ajrccm/146.6.1434. [DOI] [PubMed] [Google Scholar]
  452. Walter J. E., Coffee E. G. Distribution and epidemiologic significance of the serotypes of Cryptococcus neoformans. Am J Epidemiol. 1968 Jan;87(1):167–172. doi: 10.1093/oxfordjournals.aje.a120797. [DOI] [PubMed] [Google Scholar]
  453. Warr W., Bates J. H., Stone A. The spectrum of pulmonary cryptococcosis. Ann Intern Med. 1968 Dec;69(6):1109–1116. doi: 10.7326/0003-4819-69-6-1109. [DOI] [PubMed] [Google Scholar]
  454. Wasser L., Talavera W. Pulmonary cryptococcosis in AIDS. Chest. 1987 Oct;92(4):692–695. doi: 10.1378/chest.92.4.692. [DOI] [PubMed] [Google Scholar]
  455. Wehn S. M., Heinz E. R., Burger P. C., Boyko O. B. Dilated Virchow-Robin spaces in cryptococcal meningitis associated with AIDS: CT and MR findings. J Comput Assist Tomogr. 1989 Sep-Oct;13(5):756–762. doi: 10.1097/00004728-198909000-00002. [DOI] [PubMed] [Google Scholar]
  456. Weinberg P. B., Becker S., Granger D. L., Koren H. S. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages. Am Rev Respir Dis. 1987 Nov;136(5):1242–1247. doi: 10.1164/ajrccm/136.5.1242. [DOI] [PubMed] [Google Scholar]
  457. Weinstein L., Jacoby I. Successful treatment of cerebral cryptococcoma and meningitis with miconazole. Ann Intern Med. 1980 Oct;93(4):569–571. doi: 10.7326/0003-4819-93-4-569. [DOI] [PubMed] [Google Scholar]
  458. White M., Cirrincione C., Blevins A., Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis. 1992 May;165(5):960–963. doi: 10.1093/infdis/165.5.960. [DOI] [PubMed] [Google Scholar]
  459. Whittier S., Hopfer R. L., Gilligan P. Elimination of false-positive serum reactivity in latex agglutination test for cryptococcal antigen in human immunodeficiency virus-infected population. J Clin Microbiol. 1994 Sep;32(9):2158–2161. doi: 10.1128/jcm.32.9.2158-2161.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  460. Wickes B. L., Moore T. D., Kwon-Chung K. J. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology. 1994 Mar;140(Pt 3):543–550. doi: 10.1099/00221287-140-3-543. [DOI] [PubMed] [Google Scholar]
  461. Williamson P. R. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J Bacteriol. 1994 Feb;176(3):656–664. doi: 10.1128/jb.176.3.656-664.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  462. Winans S. C., Ebert P. R., Stachel S. E., Gordon M. P., Nester E. W. A gene essential for Agrobacterium virulence is homologous to a family of positive regulatory loci. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8278–8282. doi: 10.1073/pnas.83.21.8278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  463. Witt D., McKay D., Schwam L., Goldstein D., Gold J. Acquired immune deficiency syndrome presenting as bone marrow and mediastinal cryptococcosis. Am J Med. 1987 Jan;82(1):149–150. doi: 10.1016/0002-9343(87)90394-9. [DOI] [PubMed] [Google Scholar]
  464. Wong B., Perfect J. R., Beggs S., Wright K. A. Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infect Immun. 1990 Jun;58(6):1664–1670. doi: 10.1128/iai.58.6.1664-1670.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  465. Wong K. F., Ma S. K., Chan J. K., Lam K. W. Acquired immunodeficiency syndrome presenting as marrow cryptococcosis. Am J Hematol. 1993 Apr;42(4):392–394. doi: 10.1002/ajh.2830420412. [DOI] [PubMed] [Google Scholar]
  466. Wu T. C., Koo S. Y. Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen. J Clin Microbiol. 1983 Nov;18(5):1127–1130. doi: 10.1128/jcm.18.5.1127-1130.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  467. Yagupsky P., Menegus M. A. Cumulative positivity rates of multiple blood cultures for Mycobacterium avium-intracellulare and Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1990 Sep;114(9):923–925. [PubMed] [Google Scholar]
  468. Young B. J., Kozel T. R. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect Immun. 1993 Jul;61(7):2966–2972. doi: 10.1128/iai.61.7.2966-2972.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  469. Young E. J., Hirsh D. D., Fainstein V., Williams T. W. Pleural effusions due to Cryptococcus neoformans: a review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis. 1980 Apr;121(4):743–747. doi: 10.1164/arrd.1980.121.4.743. [DOI] [PubMed] [Google Scholar]
  470. Zimmer B. L., Roberts G. D. Rapid selective urease test for presumptive identification of Cryptococcus neoformans. J Clin Microbiol. 1979 Sep;10(3):380–381. doi: 10.1128/jcm.10.3.380-381.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  471. Zlupko G. M., Fochler F. J., Goldschmidt Z. H. Pulmonary cryptococcosis presenting with multiple pulmonary nodules. Chest. 1980 Apr;77(4):575–575. doi: 10.1378/chest.77.4.575. [DOI] [PubMed] [Google Scholar]
  472. Zoller W. G., Kellner H., Goebel F. D., Schmiedtke K., Holecek B., Staib F., Seibold M., Zöllner N. Cryptococcus neoformans-Meningoencephalitis und Mehrfachinfektionen bei AIDS. Klin Wochenschr. 1989 Jun 1;67(11):598–604. doi: 10.1007/BF01721688. [DOI] [PubMed] [Google Scholar]
  473. Zuger A., Louie E., Holzman R. S., Simberkoff M. S., Rahal J. J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med. 1986 Feb;104(2):234–240. doi: 10.7326/0003-4819-104-2-234. [DOI] [PubMed] [Google Scholar]
  474. de Gans J., Eeftinck Schattenkerk J. K., van Ketel R. J. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome. Br Med J (Clin Res Ed) 1988 Jan 30;296(6618):339–339. doi: 10.1136/bmj.296.6618.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  475. de Gans J., Portegies P., Tiessens G., Eeftinck Schattenkerk J. K., van Boxtel C. J., van Ketel R. J., Stam J. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS. 1992 Feb;6(2):185–190. doi: 10.1097/00002030-199202000-00007. [DOI] [PubMed] [Google Scholar]
  476. el-Zaatari M., Pasarell L., McGinnis M. R., Buckner J., Land G. A., Salkin I. F. Evaluation of the updated Vitek yeast identification data base. J Clin Microbiol. 1990 Sep;28(9):1938–1941. doi: 10.1128/jcm.28.9.1938-1941.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  477. van Gemert H. M., Vermeulen M. Treatment of impaired consciousness with lumbar punctures in a patient with cryptococcal meningitis and AIDS. Clin Neurol Neurosurg. 1991;93(3):257–258. doi: 10.1016/s0303-8467(05)80016-2. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES